1
|
Felix M, Vanegas E, Sarfraz A, Sarfraz Z, Camacho G, Barrios-Ruiz A, Michel J, Yukselen Z, Agolli A, Molina DMA, Cejudo P, Robles-Velasco K, Bajaña MJF, Calderón JC, Cortes-Telles A, Cherrez-Ojeda I. Knowledge and perceptions regarding pulmonary rehabilitation amongst Ecuadorian physicians following COVID-19 outbreak. Multidiscip Respir Med 2024; 19:919. [PMID: 38516292 PMCID: PMC10956887 DOI: 10.5826/mrm.2024.919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 10/20/2023] [Indexed: 03/23/2024] Open
Abstract
Background Pulmonary rehabilitation is already an established technique for patients with chronic respiratory disease, aimed at improving breathlessness, exercise capacity, health status, and well-being. The aim of this study was to assess the knowledge and perceptions about pulmonary rehabilitation post-COVID-19 infection among Ecuadorian physicians. Methods We conducted a cross-sectional online survey-based study using a 27-item questionnaire to assess the knowledge about specific topics related to pulmonary rehabilitation. The sample comprised Ecuadorian physicians who were currently enrolled to an active medical practice that included care to COVID-19 patients. Descriptive statistics were applied for demographic variables of interest. A chi-square goodness of fit test was used to determine whether the observed frequencies of each of the answers per query were within or outside of the expected frequencies by chance. Results In total, 295 participants answered the survey, out of which 57.3% were general practitioners. Most agreed that COVID-19 infected patients must be followed-up with some measurement of respiratory function (81.4%, p=0.000), but only 18.3% (n=54, p=0.000) were aware of specific guidelines related to rehabilitation. 93.6% (n=276, p=0.000) considered that pulmonary rehabilitation provides a benefit, of any kind, to patients with past COVID-19 infection. Conclusions Most physicians considered pulmonary rehabilitation beneficial following COVID-19. However, there is uncertainty on how to adequately follow up patients, complementary tests, and specific guidelines outlining rehabilitative interventions.
Collapse
Affiliation(s)
- Miguel Felix
- Department of Medicine, New York City Health + Hospitals/Lincoln, Bronx, New York, USA
| | - Emanuel Vanegas
- Department of Medicine, New York City Health + Hospitals/Woodhull, Brooklyn, New York, USA
| | - Azza Sarfraz
- Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan
| | - Zouina Sarfraz
- Department of Medicine, New York City Health + Hospitals/Woodhull, Brooklyn, New York, USA
- Research & Publications, Fatima Jinnah Medical University, Lahore, Pakistan
| | - Genesis Camacho
- División de Estudios para Graduados, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
| | - Alanna Barrios-Ruiz
- Division of Clinical and Translational Research, Larkin Community Hospital, South Miami, FL, USA
- Instituto Tecnológico y de Estudios Superiores de Monterrey, México
| | - Jack Michel
- Division of Clinical and Translational Research, Larkin Community Hospital, South Miami, FL, USA
| | - Zeynep Yukselen
- School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA
| | - Arjola Agolli
- Division of Clinical and Translational Research, Larkin Community Hospital, South Miami, FL, USA
| | | | - Pilar Cejudo
- Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | - Karla Robles-Velasco
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Group, Guayaquil, Ecuador
| | | | - Juan Carlos Calderón
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Group, Guayaquil, Ecuador
| | - Arturo Cortes-Telles
- Department of Medicine, New York City Health + Hospitals/Lincoln, Bronx, New York, USA
- Department of Medicine, New York City Health + Hospitals/Woodhull, Brooklyn, New York, USA
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
2
|
Cherrez‐Ojeda I, Bousquet J, Sarfraz Z, Sarfraz A, Rodriguez Gonzales M, Bedbrook A, Rosario N, Zepeda‐Ortega B, Guidos G, Alcivar Molina U, Felix M, Vanegas E, Robles‐Velasco K, Zimmermann LJ, Gavilanes AWD. Exploring the role of information and communication technologies in allergic rhinitis in specialist centers: Patient perspectives on usefulness, value, and impact on healthcare. Clin Transl Allergy 2024; 14:e12325. [PMID: 38282193 PMCID: PMC10799206 DOI: 10.1002/clt2.12325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Revised: 11/16/2023] [Accepted: 12/07/2023] [Indexed: 01/30/2024] Open
Abstract
INTRODUCTION Information and communication technologies (ICTs) improve patient-centered care and are routinely used in Allergic Rhinitis (AR), but patients' preferences and attitudes are unexplored. This study examines AR-related information preferences and ICT use by AR patients. METHODS A survey-based cross-sectional study was carried out in Ecuador from July to September 2019 in seven centers of reference for allergic disease. Participants were 18 years or older, diagnosed with AR and had access to ICT and the Internet. Descriptive and binomial logistic regressions were performed. A value of less than 0.05 was considered statistically significant. RESULTS 217 patients were included. 47% (n = 102) used ICTs to learn about AR, of which 38.2% (n = 83) found it useful. Most of participants (75%, n = 164) did not think that ICTs reduce their need to see a doctor. Individuals with poorer quality of life were more likely to utilize ICTs to contact their doctor (OR 1.27, 95% CI 1.04-1.55), and more likely to be interested in AR-related content (OR 1.23, 95% CI 1.00-1.52). Patients with long-term AR or other allergies were less likely to use ICTs (OR 0.92 and OR 0.40 respectively). Higher education and lower quality of life may increase AR apps adoption (OR 4.82, 95% CI 1.11-21.00). Academic preparation five-fold increased ICT use for health provider communication (OR 5.29, 95% CI 1.18-23.72). Mild-persistent AR enhanced the probabilities of using ICTs to share experiences and communicate with other patients (OR 12.59, 95% CI 1.32-120.35). CONCLUSIONS Our study emphasizes the importance of tailoring digital resources to patient needs by considering factors such as quality of life, education, and specific subgroups within the AR patient population. Additionally, the findings suggest that while ICTs can play a valuable role in patient education and support, they should complement, rather than replace, traditional medical care for many AR patients.
Collapse
Affiliation(s)
- Ivan Cherrez‐Ojeda
- Universidad Espíritu SantoSamborondónEcuador
- Respiralab Research GroupGuayaquilEcuador
| | - Jean Bousquet
- Institute of AllergologyCharité – Universitätsmedizin BerlinCorporate Member of Freie Universität Berlin and Humboldt‐Universität zu BerlinBerlinGermany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMPAllergology and ImmunologyBerlinGermany
- University Hospital of MontpellierMontpellierFrance
| | - Zouina Sarfraz
- Research and PublicationsFatima Jinnah Medical UniversityLahorePakistan
| | - Azza Sarfraz
- Pediatrics and Child HealthThe Aga Khan UniversityKarachiPakistan
| | - Monica Rodriguez Gonzales
- Urticaria Center of Reference and Excellence (UCARE)Department of AllergyHospital Español de MéxicoMexico CityMexico
| | | | | | - Benjamin Zepeda‐Ortega
- Pediatric Allergist Private PracticeAngeles Lomas Hospital Huixquilucan Mexican StateMexico CityMexico
| | - Guillermo Guidos
- Department of ImmunologySchool of MedicineInstituto Politecnico NacionalGustavo A. MaderoCDMXMexico CityMexico
| | | | - Miguel Felix
- Universidad Espíritu SantoSamborondónEcuador
- Respiralab Research GroupGuayaquilEcuador
| | - Emanuel Vanegas
- Universidad Espíritu SantoSamborondónEcuador
- Respiralab Research GroupGuayaquilEcuador
| | - Karla Robles‐Velasco
- Universidad Espíritu SantoSamborondónEcuador
- Respiralab Research GroupGuayaquilEcuador
| | - Luc J. Zimmermann
- School for Oncology & Developmental Biology (GROW)University of MaastrichtMaastrichtNetherlands
| | - Antonio W. D. Gavilanes
- School for Oncology & Developmental Biology (GROW)University of MaastrichtMaastrichtNetherlands
- Instituto de Investigación E Innovación en Salud IntegralLaboratorio de BiomedicinaFacultad de Ciencias MédicasUniversidad Católica de Santiago de GuayaquilGuayaquilEcuador
| |
Collapse
|
3
|
Morais A, Morais J, Felix M, Neto Z, Madaleno V, Umar AS, Panda N, Lemma F, Chivale JAL, Cavalcante DG, Davlantes E, Ghiselli M, Espinosa C, Whiteman A, Iber J, Henderson E, Bullard K, Jorba J, Burns CC, Diop O, Gumede N, Seakamela L, Howard W, Frawley A. Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019-2020. Vaccine 2023; 41 Suppl 1:A48-A57. [PMID: 36803869 PMCID: PMC10823914 DOI: 10.1016/j.vaccine.2023.02.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Revised: 02/06/2023] [Accepted: 02/10/2023] [Indexed: 02/19/2023]
Abstract
After six years without any detection of poliomyelitis cases, Angola reported a case of circulating vaccine-derived poliovirus type 2 (cVDPV2) with paralysis onset date of 27 March 2019. Ultimately, 141 cVDPV2 polio cases were reported in all 18 provinces in 2019-2020, with particularly large hotspots in the south-central provinces of Luanda, Cuanza Sul, and Huambo. Most cases were reported from August to December 2019, with a peak of 15 cases in October 2019. These cases were classified into five distinct genetic emergences (emergence groups) and have ties with cases identified in 2017-2018 in the Democratic Republic of Congo. From June 2019 to July 2020, the Angola Ministry of Health and partners conducted 30 supplementary immunization activity (SIA) rounds as part of 10 campaign groups, using monovalent OPV type 2 (mOPV2). There were Sabin 2 vaccine strain detections in the environmental (sewage) samples taken after mOPV2 SIAs in each province. Following the initial response, additional cVDPV2 polio cases occurred in other provinces. However, the national surveillance system did not detect any new cVDPV2 polio cases after 9 February 2020. While reporting subpar indicator performance in epidemiological surveillance, the laboratory and environmental data as of May 2021 strongly suggest that Angola successfully interrupted transmission of cVDPV2 early in 2020. Additionally, the COVID-19 pandemic did not allow a formal Outbreak Response Assessment (OBRA). Improving the sensitivity of the surveillance system and the completeness of AFP case investigations will be vital to promptly detect and interrupt viral transmission if a new case or sewage isolate are identified in Angola or central Africa.
Collapse
Affiliation(s)
- Alda Morais
- Angola Ministry of Health. R. 17 de Setembro, Luanda, Angola
| | - Joana Morais
- Angola Ministry of Health. R. 17 de Setembro, Luanda, Angola
| | - Miguel Felix
- Angola Ministry of Health. R. 17 de Setembro, Luanda, Angola
| | - Zoraima Neto
- Angola Ministry of Health. R. 17 de Setembro, Luanda, Angola
| | | | - Abubakar Sadiq Umar
- World Health Organization, Angola Country Office. Condomínio Rosalinda, Edifício da ONU, Estrada Direita da Samba, Futungo de Belas, Luanda, Angola
| | - Nirakar Panda
- World Health Organization, Angola Country Office. Condomínio Rosalinda, Edifício da ONU, Estrada Direita da Samba, Futungo de Belas, Luanda, Angola
| | - Fekadu Lemma
- World Health Organization, Angola Country Office. Condomínio Rosalinda, Edifício da ONU, Estrada Direita da Samba, Futungo de Belas, Luanda, Angola
| | - José Alexandre Lifande Chivale
- World Health Organization, Angola Country Office. Condomínio Rosalinda, Edifício da ONU, Estrada Direita da Samba, Futungo de Belas, Luanda, Angola
| | - Danielle Graça Cavalcante
- World Health Organization, Angola Country Office. Condomínio Rosalinda, Edifício da ONU, Estrada Direita da Samba, Futungo de Belas, Luanda, Angola
| | - Elizabeth Davlantes
- Global Immunization Division, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA.
| | - Margherita Ghiselli
- Global Immunization Division, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Catherine Espinosa
- Global Immunization Division, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Ari Whiteman
- Geospatial Research, Analysis, and Services Program, US Agency for Toxic Substances and Disease Registry. 4770, Buford Hwy Northeast, Atlanta, GA, USA
| | - Jane Iber
- Division of Viral Diseases, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Elizabeth Henderson
- Division of Viral Diseases, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Kelley Bullard
- Division of Viral Diseases, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Jaume Jorba
- Division of Viral Diseases, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Cara C Burns
- Division of Viral Diseases, US Centers for Disease Control and Prevention. 1600 Clifton Road, Atlanta, GA, USA
| | - Ousmane Diop
- Polio Eradication Department, World Health Organization, Avenue Appia, 20, 1211, Geneva 27, Switzerland
| | - Nicksy Gumede
- World Health Organization Regional Office for Africa. Cité du Djoué, P.O. Box 06, Brazzaville, Republic of Congo
| | - Lerato Seakamela
- National Institute for Communicable Diseases, 1, Modderfontein Road, Sandringham, Johannesburg 2192, South Africa
| | - Wayne Howard
- National Institute for Communicable Diseases, 1, Modderfontein Road, Sandringham, Johannesburg 2192, South Africa
| | - Alean Frawley
- US Centers for Disease Control and Prevention, Angola Country Office, R. Houari Boumediene 32, Luanda, Angola
| |
Collapse
|
4
|
Valdevilla Figueira JA, Mautong H, Camacho L G, Cherrez M, Orellana Román C, Alvarado-Villa GE, Sarfraz Z, Sarfraz A, Agolli A, Farfán Bajaña MJ, Vanegas E, Felix M, Michel J, Espinoza-Fuentes F, Maquilón JR, Cherrez Ojeda I. Attitudes toward depression among Ecuadorian physicians using the Spanish-validated version of the Revised Depression Attitude Questionnaire (R-DAQ). BMC Psychol 2023; 11:46. [PMID: 36793136 PMCID: PMC9930300 DOI: 10.1186/s40359-023-01072-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Accepted: 01/31/2023] [Indexed: 02/17/2023] Open
Abstract
PURPOSE Depression is inadequately recognized and managed, and physicians' attitudes toward this condition and its treatment may play a part in this. This study aimed to assess Ecuadorian physicians' attitudes toward depression. METHODS This was a cross-sectional study conducted using the validated Revised Depression Attitude Questionnaire (R-DAQ). The questionnaire was delivered to Ecuadorian physicians, and the response rate was 88.8%. RESULTS 76.4% of participants had never received previous training in depression, and 52.1% of them indicated neutral or limited professional confidence when dealing with depressed patients. More than two-thirds of the participants reported an optimistic attitude toward the generalist perspective of depression. CONCLUSION Overall, physicians in Ecuador's healthcare settings were optimistic and held positive attitudes toward patients with depression. However, a lack of confidence in the management of depression and a need for ongoing training were found, especially among medical professionals who are not in daily contact with patients with depression.
Collapse
Affiliation(s)
- José Alejandro Valdevilla Figueira
- Instituto de Neurociencias, Guayaquil, Ecuador ,Departamento de Psicología. Facultad de Marketing, Universidad Ecotec, Guayaquil, Ecuador
| | - Hans Mautong
- Respiralab Research Group, Guayaquil, Ecuador ,grid.442156.00000 0000 9557 7590Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952 Samborondón, Ecuador
| | - Genesis Camacho L
- grid.411267.70000 0001 2168 1114Universidad del Zulia, Maracaibo, Venezuela
| | | | | | | | - Zouina Sarfraz
- grid.414774.50000 0000 9694 4612Research and Publications, Fatima Jinnah Medical University, Lahore, Pakistan
| | - Azza Sarfraz
- grid.7147.50000 0001 0633 6224Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan
| | - Arjola Agolli
- Division of Clinical and Translational Research, Larkin Healthcare System, Miami, USA
| | - María José Farfán Bajaña
- Respiralab Research Group, Guayaquil, Ecuador ,grid.442156.00000 0000 9557 7590Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952 Samborondón, Ecuador
| | - Emanuel Vanegas
- Respiralab Research Group, Guayaquil, Ecuador ,grid.442156.00000 0000 9557 7590Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952 Samborondón, Ecuador ,grid.422616.50000 0004 0443 7226New York City Health + Hospitals, Woodhull, Brooklyn, NY USA
| | - Miguel Felix
- Respiralab Research Group, Guayaquil, Ecuador ,grid.442156.00000 0000 9557 7590Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952 Samborondón, Ecuador ,grid.422616.50000 0004 0443 7226New York City Health + Hospitals, Lincoln, Bronx, NY USA
| | - Jack Michel
- Division of Clinical and Translational Research, Larkin Healthcare System, Miami, USA
| | - Fernando Espinoza-Fuentes
- grid.442156.00000 0000 9557 7590Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952 Samborondón, Ecuador
| | | | - Ivan Cherrez Ojeda
- Respiralab Research Group, Guayaquil, Ecuador. .,Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952, Samborondón, Ecuador.
| |
Collapse
|
5
|
Farrukh S, Habib S, Rafaqat A, Sarfraz Z, Sarfraz A, Sarfraz M, Robles-Velasco K, Felix M, Cherrez-Ojeda I. Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review. Healthcare (Basel) 2023; 11:healthcare11040559. [PMID: 36833093 PMCID: PMC9956230 DOI: 10.3390/healthcare11040559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 01/19/2023] [Accepted: 01/30/2023] [Indexed: 02/16/2023] Open
Abstract
BACKGROUND Of all central nervous systems tumors, 10-20% are located in the brainstem; diffuse intrinsic pontine glioma (DIPG) is diagnosed in 80% of them. With over five decades of clinical trial testing, there are no established therapeutic options for DIPG. This research article aims to collate recent clinical trial data and provide a landscape for the most promising therapies that have emerged in the past five years. METHODS PubMed/MEDLINE, Web of Science, Scopus, and Cochrane were systematically searched using the following keywords: Diffuse intrinsic pontine glioma, Pontine, Glioma, Treatment, Therapy, Therapeutics, curative, and/or Management. Both adult and pediatric patients with newly diagnosed or progressive DIPG were considered in the clinical trial setting. The risk of bias was assessed using the ROBINS-I tool. RESULTS A total of 22 trials were included reporting the efficacy and safety outcomes among patients. First, five trials reported outcomes of blood-brain barrier bypass via single or repeated-dose intra-arterial therapy or convection-enhanced delivery. Second, external beam radiation regimens were assessed for safety and efficacy in three trials. Third, four trials administered intravenous treatment without using chemotherapeutic regimens. Fourth, eight trials reported the combinations of one or more chemotherapeutic agents. Fifth, immunotherapy was reported in two trials in an adjuvant monotherapy in the post-radiotherapy setting. CONCLUSION This research article captures a clinical picture of the last five years of the direction toward which DIPG research is heading. The article finds that re-irradiation may prolong survival in patients with progressive DIPG; it also instills that insofar palliative radiotherapy has been a key prognostic choice.
Collapse
Affiliation(s)
- Shahrukh Farrukh
- Department of Research, Khawaja Muhammad Safdar Medical College, Sialkot 51310, Pakistan
| | - Shagufta Habib
- Department of Research, University Medical and Dental College Faisalabad, Faisalabad 38800, Pakistan
| | - Amna Rafaqat
- Department of Research and Publications, Fatima Jinnah Medical University, Lahore 54000, Pakistan
| | - Zouina Sarfraz
- Department of Research and Publications, Fatima Jinnah Medical University, Lahore 54000, Pakistan
| | - Azza Sarfraz
- Department of Pediatrics and Child Health, The Aga Khan University, Karachi 74000, Pakistan
- Correspondence: (A.S.); (I.C.-O.)
| | | | - Karla Robles-Velasco
- Department of Allergy, Immunology and Pulmonary Medicine, Universidad Espíritu Santo, Samborondón 092301, Ecuador
| | - Miguel Felix
- Department of Internal Medicine, New York City Health + Hospitals, Lincoln, The Bronx, NY 10451, USA
| | - Ivan Cherrez-Ojeda
- Department of Allergy, Immunology and Pulmonary Medicine, Universidad Espíritu Santo, Samborondón 092301, Ecuador
- Correspondence: (A.S.); (I.C.-O.)
| |
Collapse
|
6
|
Munir T, Akbar MS, Ahmed S, Sarfraz A, Sarfraz Z, Sarfraz M, Felix M, Cherrez-Ojeda I. A Systematic Review of Internet of Things in Clinical Laboratories: Opportunities, Advantages, and Challenges. Sensors (Basel) 2022; 22:8051. [PMID: 36298402 PMCID: PMC9611742 DOI: 10.3390/s22208051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 10/10/2022] [Accepted: 10/11/2022] [Indexed: 06/16/2023]
Abstract
The Internet of Things (IoT) is the network of physical objects embedded with sensors, software, electronics, and online connectivity systems. This study explores the role of IoT in clinical laboratory processes; this systematic review was conducted adhering to the PRISMA Statement 2020 guidelines. We included IoT models and applications across preanalytical, analytical, and postanalytical laboratory processes. PubMed, Cochrane Central, CINAHL Plus, Scopus, IEEE, and A.C.M. Digital library were searched between August 2015 to August 2022; the data were tabulated. Cohen's coefficient of agreement was calculated to quantify inter-reviewer agreements; a total of 18 studies were included with Cohen's coefficient computed to be 0.91. The included studies were divided into three classifications based on availability, including preanalytical, analytical, and postanalytical. The majority (77.8%) of the studies were real-tested. Communication-based approaches were the most common (83.3%), followed by application-based approaches (44.4%) and sensor-based approaches (33.3%) among the included studies. Open issues and challenges across the included studies included scalability, costs and energy consumption, interoperability, privacy and security, and performance issues. In this study, we identified, classified, and evaluated IoT applicability in clinical laboratory systems. This study presents pertinent findings for IoT development across clinical laboratory systems, for which it is essential that more rigorous and efficient testing and studies be conducted in the future.
Collapse
Affiliation(s)
- Tahir Munir
- Department of Research, Nishtar Medical University, Multan 66000, Pakistan
| | | | - Sadia Ahmed
- Department of Research, Punjab Medical College, Faisalabad 38000, Pakistan
| | - Azza Sarfraz
- Department of Pediatrics and Child Health, The Aga Khan University, Karachi 74800, Pakistan
| | - Zouina Sarfraz
- Department of Research and Publications, Fatima Jinnah Medical University, Lahore 54000, Pakistan
| | - Muzna Sarfraz
- Department of Research, King Edward Medical University, Lahore 54000, Pakistan
| | - Miguel Felix
- Department of Pulmonology, Universidad Espíritu Santo, Samborondón 092301, Ecuador
| | - Ivan Cherrez-Ojeda
- Department of Pulmonology, Universidad Espíritu Santo, Samborondón 092301, Ecuador
| |
Collapse
|
7
|
Sarfraz M, Sarfraz A, Sarfraz Z, Nadeem Z, Khalid J, Butt SZ, Thevuthasan S, Felix M, Cherrez-Ojeda I. Contributing factors to pediatric COVID-19 and MIS-C during the initial waves: A systematic review of 92 case reports. Ann Med Surg (Lond) 2022; 81:104227. [PMID: 35937636 PMCID: PMC9339082 DOI: 10.1016/j.amsu.2022.104227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 07/19/2022] [Accepted: 07/20/2022] [Indexed: 11/25/2022] Open
Abstract
Background As the coronavirus disease 2019 (COVID-19) pandemic continues to sweep the world with unprecedented speed and devastation, data has shown that cases in the pediatric population have been significantly lower than in the adult population. We conducted a systematic review of case reports to identify the contributing factors of confirmed pediatric COVID-19 patients. Methods Using the PubMed platform, and Cochrane Central, we searched for primary studies alone. All database searches were performed between December 2019 and December 2020. We incorporated keywords including “pediatrics,” “Case reports,” “Cases,” “Covid-19″ into all searches. Results A total of 92 records were included in this novel review. Of all patients, 58% were male and the mean age of the patients was 6.2 years (SD: 5.9). Contributing factors to MIS-C infections were G6PD deficiency (17.6%), Group A streptococcus co-infection (17.6%), infancy (11.8%), whereas those in COVID-19 pediatric patients included congenital (18.5%), and genetic defects (13.8%), in addition to vertical transmission or during infancy (16.9%). Data of baseline demographic characteristics and clinical sequelae of included COVID-19 pediatric and MIS-C patients is presented. Conclusion With schools reopening and closing, the pediatric age group is susceptible to high rates of COVID-19 community transmission. We provide insights into potential contributing factors to pediatric COVID-19 and MIS-C patients. These insights are critical to guide future guidelines on the management and potential vaccination efforts. COVID-19 continues to devastate communities worldwide. The pediatric population has faced the ups and downs of the many variants of disease. This systematic review includes a total of 92 studies and identifies key contributing factors from developmental, maternal and pediatric. We provide insights into potential contributing factors to pediatric COVID-19 and MIS-C patients. These insights are critical to guide future guidelines on the management and potential vaccination efforts.
Collapse
|
8
|
Sarfraz A, Sarfraz Z, Sarfraz M, Nadeem Z, Felix M, Cherrez-Ojeda I. Menstrual irregularities following COVID-19 vaccination: A global cross-sectional survey. Ann Med Surg (Lond) 2022; 81:104220. [PMID: 35957648 PMCID: PMC9356761 DOI: 10.1016/j.amsu.2022.104220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 07/12/2022] [Accepted: 07/19/2022] [Indexed: 11/28/2022] Open
Affiliation(s)
- Azza Sarfraz
- The Aga Khan University, Karachi, Pakistan
- Corresponding author. Department of Pediatrics and Child Health, Faculty Office Building, Aga Khan University, P.O. Box: 3500, Stadium Road, Karachi, 74800, Pakistan.
| | - Zouina Sarfraz
- Fatima Jinnah Medical University, Lahore, Pakistan
- Corresponding author. Fatima Jinnah Medical University, Queen's Road, Mozang Chungi, Lahore, Punjab, 54000, Pakistan.
| | | | | | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
- Corresponding author. Universidad Espíritu Santo, Km. 2Vía La Puntilla, Samborondón, 0901, Ecuador.
| |
Collapse
|
9
|
Sarfraz Z, Sarfraz A, Sarfraz M, Azeem N, Hange N, Felix M, Cherrez-Ojeda I. Social contributors for the rise of COVID-19 infections in South Asia: A large cross-sectional survey. Ann Med Surg (Lond) 2022; 80:104212. [PMID: 35874934 PMCID: PMC9293386 DOI: 10.1016/j.amsu.2022.104212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 07/12/2022] [Accepted: 07/12/2022] [Indexed: 11/26/2022] Open
Abstract
Background The ongoing global coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in South Asia on 30th January 2020 in India. Ever since, certain countries have witnessed multiple waves of COVID-19, requiring attention by public health experts and strategists in the region. The objectives of this study are to assess social contributors to the recurrent waves of COVID-19 in South Asia including first demographic traits, second household characteristics and social measures, third workplace trends and personal protective equipment use, and fourth satisfaction and attitudes concerning public health measures and vaccination status. The study also aims to plan for control strategies focusing on India, Pakistan, Bangladesh, Sri Lanka, and Nepal, countries with the highest burden of COVID-19 in South Asia. Methods A population-based large cross-sectional study was conducted from 1st July to August 10th, 2021 using online mediums. The survey consisted of 31 questions divided into sociodemographic and COVID-19 status information, household characteristics and social measures, workplace trends and personal protective measures, satisfaction and attitudes towards public health measures, and vaccination status. Bivariate, receiver operating characteristic (ROC) analysis, and the Kruskal Wallis test was conducted for factors associated to COVID-19 infection and positive vaccination status. Findings We enrolled 1046 participants with 57.1% females and 41.8% males, comprising 48.9% healthcare workers. Statistically significant associations were found using ANOVA based on the Kruskal-Wallis test for differences between thoughts towards public health authorities implementing standard operating procedures (SOPs) and HCW status were statistically significant (P = 0.002). The most important social predictors for positive vaccination status based on the ROC analysis were gender (P < 0.001), job role (P < 0.001), income group (P < 0.001), healthcare worker status (P < 0.001), household member tested positive (P = 0.007), personal vehicle ownership (P < 0.001), job requiring close contacts (P < 0.001) and co-worker masking habits (P = 0.02). Conclusions Public health experts and strategists are required to focus control strategies on political and religious gatherings, reopening offices, noncompliance of SOPs by the masses, and crowded commuting to limit the reemergence of COVID-19 infections in countries with the highest burden in the region. The COVID-19 pandemic has spread across the South Asian region. Some countries such as Nepal and India amid others witnessed multiple deadly waves of the pandemic. This large cross-sectional survey assesses the social contributors to the rise of COVID-19 in South Asia. We assess demographic, social, workplaces, and personal trends. Various countries have employed public health restrictions to mitigate the spread of COVID-19. We contribute to public health surveillance data essential to make pivotal shifts in social policies and practice.
Collapse
|
10
|
Sarfraz A, Sarfraz Z, Camacho-Leon G, Alvarado-Villa GE, Andrade-Molina DM, Fernandez-Cadena JC, Agolli A, Yukselen Z, Felix M, Gallardo Bastidas JC, Espinoza-Fuentes F, Michel J, Cherrez-Ojeda I. Impact of biosecurity measures, social pressure and bullying on attitudes, perceptions, and job satisfaction levels among healthcare workers during the COVID-19 pandemic: a cross-sectional survey. BMJ Open 2022; 12:e056952. [PMID: 35879003 PMCID: PMC9327436 DOI: 10.1136/bmjopen-2021-056952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
INTRODUCTION The extent and nature of social pressure and bullying towards healthcare workers (HCWs) during the COVID-19 remains unclear. The following study identifies the effect of social pressure and bullying directed towards HCWs when using biosecurity measures during the COVID-19 pandemic; further, the impact on perceptions, attitudes and job satisfaction level is also explored. METHODOLOGY We conducted a cross-sectional survey-based study among 684 Ecuadorian HCWs. The survey consisted of 38 questions related to the frequency, attitudes, and perceptions of biosecurity measures during the COVID-19 pandemic. Exploratory factor analysis was performed to assess the validity of the questionnaire. Associations between variables were analysed using χ2 and Fisher's exact test. Using SPSS V.25, qualitative and quantitative data were analysed. RESULTS Of the 684 participants, 175 (25.59%) experienced or felt bullying or social pressure during the COVID-19 pandemic associated with the use of biosecurity measures. Of these, 40.6% believed it was due to an imbalance of power in the workplace. The perception that HCWs wearing personal protective equipment resulting in bullying was noted in 12% of the respondents. Job satisfaction was positive among 73% of the respondents. Gender (female) and type of institution (public) were noted to contribute towards job satisfaction and bullying experiences. CONCLUSION Exposure to social bullying and pressure due to the use of biosecurity measures during the COVID-19 pandemic may result in reduced job satisfaction and thoughts about quitting work.
Collapse
Affiliation(s)
- Azza Sarfraz
- Research and Academic Affairs, Larkin Community Hospital, South Miami, FL, USA
- Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan
| | - Zouina Sarfraz
- Research and Academic Affairs, Larkin Community Hospital, South Miami, FL, USA
- Research and Publications, Fatima Jinnah Medical University, Lahore, Pakistan
| | | | | | | | | | - Arjola Agolli
- Research and Academic Affairs, Larkin Community Hospital, South Miami, FL, USA
| | - Zeynep Yukselen
- Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts, USA
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Group, Guayaquil, Ecuador
- Department of Medicine, New York City Health + Hospitals/Lincoln, Bronx, New York, New York, USA
| | | | | | - Jack Michel
- Research and Academic Affairs, Larkin Community Hospital, South Miami, FL, USA
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
11
|
Naveed Z, Sarwar M, Ali Z, Saeed D, Choudhry K, Sarfraz A, Sarfraz Z, Felix M, Cherrez-Ojeda I. Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysis. J Clin Lab Anal 2022; 36:e24434. [PMID: 35435272 PMCID: PMC9110982 DOI: 10.1002/jcla.24434] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 04/03/2022] [Accepted: 04/04/2022] [Indexed: 01/23/2023] Open
Abstract
Introduction Anakinra is being empirically considered for the treatment of COVID‐19 patients. The aim is to assess the efficacy of anakinra treatment on inflammatory marker reduction, including c‐reactive protein (CRP) concentrations, serum ferritin, and serum d‐dimer levels. Methods Adhering to PRISMA 2020 statement guidelines, a systematic search was conducted across the following databases from December 2019 until January 10, 2022: PubMed/MEDLINE, Cochrane Central, Web of Science, Scopus, and EMBASE. The following keywords were employed: Anakinra, COVID*, SARS‐CoV‐2, inflammatory, CRP, D‐dimer, Ferritin, hematological, laboratory, clinical, trials. The findings were collated and presented in a tabulated manner, and statistically analyzed using Review Manger 5.4 (Cochrane). Results In total, 2032 patients were included (881 in the anakinra and 1151 in the control/standard care group); 69.1% of them were males. Overall, the mean difference from admission until last follow‐up in CRP values was −9.66, where notable reductions were seen in the anakinra group (SMD = −0.46, p < 0.00001, N = 655). Serum ferritin mean values were reduced by 1467.16 in the anakinra group (SMD = −0.31, p = 0.004, N = 537). D‐dimer mean values were largely reduced by 4.04 in the anakinra group (SMD = −0.38, p = 0.0004, N = 375). Conclusion This study finds that anakinra is potentially a strong candidate as an anti‐inflammatory agent to reduce mortality in COVID‐19 patients, specifically in patients with elevated inflammatory biomarkers.
Collapse
Affiliation(s)
| | | | - Zahid Ali
- Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
| | - Danish Saeed
- Shaikh Khalifa Bin Zayed Al-Nahyan Medical and Dental College, Lahore, Pakistan
| | | | | | | | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
12
|
Cherrez-Ojeda I, Vanegas E, Felix M, Farfán Bajaña MJ, Sarfraz A, Sarfraz Z, Camacho G, Barrios-Ruiz A, Michel J. Physician’s attitudes on pulmonary rehabilitation following COVID-19: a brief perspective from a developing country. Multidiscip Respir Med 2022; 17:837. [PMID: 35498534 PMCID: PMC9044897 DOI: 10.4081/mrm.2022.837] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Accepted: 03/24/2022] [Indexed: 11/23/2022] Open
Abstract
Despite the uncertainty about the follow up of COVID-19 survivors, there is a growing body of evidence supporting specific interventions including pulmonary rehabilitation, which may lead to a reduced hospital stay and improved overall respiratory function. The aim of this short report was to assess the attitudes toward pulmonary rehabilitation following COVID-19 among Ecuadorian physicians. A cross-sectional study was conducted, in which a 5-question survey was used to assess the level of agreement to specific statements with a 5-point Likert scale. Out of the 282 participants, 48.2% (n=136) were male, with a mean of 12.6 (SD=11.3) years of experience. More than half of physicians (63.8%, n=180; χ2(2) = 139.224, p=0.000) considered that diagnosis and treatment of patients with sub-acute and chronic COVID-19 pulmonary sequelae is not clear. Additionally, 94.3% (n=266; χ2(2) = 497.331, p=0.000) agreed that pulmonary rehabilitation must be considered as a relevant strategy in long-term care following an acute infection, with 92.6% (n=261; χ2(2) = 449.772, p=0.000) stating it will improve the likelihood of survival and return to baseline health. In conclusion, we found that considerable majority of physicians held positive attitudes to the role of pulmonary rehabilitation and considered it as a relevant strategy in long-term care following COVID-19. However, most of them also conveyed that the diagnosis and treatment of chronic pulmonary sequalae is unclear, and that guidelines for assessing pulmonary function should be established.
Collapse
|
13
|
Jaritos VR, Vanegas E, Facundo Nogueira J, Leiva Agüero S, Giovini V, Rey de Castro J, Rodríguez Reyes Y, Luis Carrillo Alduenda J, Torres Gittaim P, Romero Z, Terán Pérez G, Angélica Bazurto M, Sarfraz A, Sarfraz Z, José Farfán Bajaña M, Mautong H, Felix M, Cherrez- Ojeda I. Frequency of use and preferences for information and communication technologies in patients with sleep apnea: a multicenter, multinational, observational cross-sectional survey study. Int J Med Inform 2022; 162:104760. [DOI: 10.1016/j.ijmedinf.2022.104760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 03/10/2022] [Accepted: 03/31/2022] [Indexed: 11/25/2022]
|
14
|
Ahmad A, Islam Z, Manzoor Ahmad S, Sarfraz Z, Sarfraz A, Felix M, Cherrez-Ojeda I. The correlation of D-dimer to stroke diagnosis within 24 hours: A meta-analysis. J Clin Lab Anal 2022; 36:e24271. [PMID: 35118733 PMCID: PMC8906038 DOI: 10.1002/jcla.24271] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Revised: 01/20/2022] [Accepted: 01/21/2022] [Indexed: 11/15/2022] Open
Abstract
Background Diagnosing D‐Dimer early is essential to optimize clinical treatment and quality of life and reduce mortality. This study aims to identify the difference of D‐Dimer levels (ng/ml) in patients with stroke within the 6‐ and 24‐h period compared to patients that mimic stroke. Methods An electronic database search across PubMed/MEDLINE, Cochrane, Web of Science, CINAHL, EMBASE, and Scopus was conducted until December 10, 2021. Studies were eligible if they included adult patients with stroke compared to stroke mimics or controls reporting D‐Dimer values. Quality assessment was conducted using GRADE. The standardized mean difference and 95% confidence intervals were calculated in addition to the difference of means in the crude form. Heterogeneity was assessed using Cochran's Q statistic and the I2 index. A random‐effects model was used. The statistical analysis was conducted using RevMan 5.4. Results Out of 2901, there were 318 (11%) participants from upper‐middle‐income countries, whereas the others were from high‐income countries. Large positive effect size was found for D‐Dimer in the stroke group (Cohen's d = 2.82 [1.73–3.9]; p < 0.00001), meaning that those with stroke had higher D‐Dimer values on presentation compared to the stroke mimics/controls. A large difference in means was found in the two groups (MD = 685.1 [324.2, 1045.99]; p < 0.00001), suggesting that there was a significantly higher laboratory value in the stroke group. Conclusion Our findings must be used in caution as the most reliable diagnostic tests for stroke are CT and MRI. Laboratory testing such as D‐Dimer values is a valuable clinical adjuvant in diagnosing total stroke.
Collapse
Affiliation(s)
- Adeel Ahmad
- Shalamar Medical and Dental College, Lahore, Pakistan
| | - Zara Islam
- Sahiwal Medical College, Sahiwal, Pakistan
| | | | | | | | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Center, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Center, Guayaquil, Ecuador
| |
Collapse
|
15
|
Vanegas E, Felix M, Farfán Bajaña MJ, Robles-Velasco K, Panchana Lascano M, Crespo Shijin C, Hinostroza Logroño R, Greiding L, Cherrez-Ojeda I. An approach to a patient with suspected meat allergy due to underlying alpha gal syndrome in a resource-limited setting: A case report. JAAD Case Rep 2022; 21:173-175. [PMID: 35252518 PMCID: PMC8888892 DOI: 10.1016/j.jdcr.2022.01.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Affiliation(s)
- Emanuel Vanegas
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
| | - Miguel Felix
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
| | - María José Farfán Bajaña
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
| | - Karla Robles-Velasco
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
| | | | - Carolina Crespo Shijin
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
| | - Romina Hinostroza Logroño
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
| | - Leonardo Greiding
- Instituto Argentino de Alergia e Inmunología, Buenos Aires, Argentina
| | - Iván Cherrez-Ojeda
- Respiralab Research Group, Guayaquil, Ecuador
- Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador
- Correspondence to: Iván Cherrez-Ojeda, MD, MSc, Universidad Espíritu Santo, School of Medicine, Km. 2.5 vía La Puntilla, Samborondón, Guayas 0901952, Ecuador.
| |
Collapse
|
16
|
Sarfraz Z, Sarfraz A, Sarfraz M, Felix M, Bernstein JA, Fonacier L, Cherrez-Ojeda I. Contact dermatitis due to personal protective equipment use and hygiene practices during the COVID-19 pandemic: A systematic review of case reports. Ann Med Surg (Lond) 2022; 74:103254. [PMID: 35039780 PMCID: PMC8755461 DOI: 10.1016/j.amsu.2022.103254] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 12/31/2021] [Accepted: 01/06/2022] [Indexed: 11/21/2022] Open
Abstract
BACKGROUND Prolonged use of personal protective equipment (PPE) may lead to contact dermatitis during the coronavirus disease 19 (COVID-19) pandemic. This paper aims to identify the causative factors of contact dermatitis from PPE and hygiene practices. METHODS The search was conducted adhering to PRISMA 2020 guidelines. A Delphi process was employed to ensure that the aims of this study were met. PubMed and Web of Science databases were systematically searched through September 12, 2021, using search terms: Contact dermatitis, case report, covid-19. The findings were tabulated as author/year, gender, age, presentation, cause, dermatological diagnosis, testing modality, provided treatment, symptom resolution (time in days), prognosis, and follow-up. RESULTS The mean age of all individuals was 29.75 years, with 75% females. All cases presented with erythema, with 62.5% reporting pruritus and 37.5% reporting burning facial symptoms. Surgical masks and hand-hygiene products (37.5%) were the most commonly reported causative agent with 25% due to KN95/FFP type 2 use. Allergic contact dermatitis (50%) and irritant contact dermatitis (25%) were common diagnoses. Treatments included creams, emollients, and desloratadine, with restriction of irritant-causing factors. The prognosis was generally good among the cases, with 62.5% presenting complete resolution within a week and 12.5% showing moderate improvement at the fourth month after discontinuing use. CONCLUSION This study finds pertinent links between PPE use and contact dermatitis during the COVID-19 pandemic. While many cases are bound to go underreported in literature, well-designed, large-scale studies in the future may help promote these associations in a more comprehensive manner.
Collapse
Affiliation(s)
| | | | | | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Jonathan A. Bernstein
- Department of Internal Medicine, University of Cincinnati College of Medicine, Ohio, USA
| | - Luz Fonacier
- Department of Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA
- Department of Allergy, New York University Winthrop Hospital, Mineola, NY, USA
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
17
|
Sarfraz A, Sarfraz Z, Sarfraz M, Abdul Razzack A, Bano S, Singh Makkar S, Thevuthasan S, Paul T, Khawar Sana M, Azeem N, Felix M, Cherrez-Ojeda I. Industry 4.0 Technologies for the Manufacturing and Distribution of COVID-19 Vaccines. J Prim Care Community Health 2022; 13:21501319211068638. [PMID: 34984932 PMCID: PMC8753236 DOI: 10.1177/21501319211068638] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
BACKGROUND The evolutionary stages of manufacturing have led us to conceptualize the use of Industry 4.0 for COVID-19 (coronavirus disease 2019), powered by Industry 4.0 technologies. Using applications of integrated process optimizations reliant on digitized data, we propose novel intelligent networks along the vaccine value chain. Vaccine 4.0 may enable maintenance processes, streamline logistics, and enable optimal production of COVID-19 vaccines. VACCINE 4.0 FRAMEWORK The challenge in applying Vaccine 4.0 includes the requirement of large-scale technologies for digitally transforming manufacturing, producing, rolling-out, and distributing vaccines. With our framework, Vaccine 4.0 analytics will target process performance, process development, process stability, compliance, quality assessment, and optimized maintenance. The benefits of digitization during and post the COVID-19 pandemic include first, the continual assurance of process control, and second, the efficacy of big-data analytics in streamlining set parameter limits. Digitization including big data-analytics may potentially improve the quality of large-scale vaccine production, profitability, and manufacturing processes. The path to Vaccine 4.0 will enhance vaccine quality, improve efficacy, and compliance with data-regulated requirements. DISCUSSION Fiscal and logistical barriers are prevalent across resource-limited countries worldwide. The Vaccine 4.0 framework accounts for expected barriers of manufacturing and equitably distributing COVID-19 vaccines. With amalgamating big data analytics and biometrics, we enable the identification of vulnerable populations who are at higher risk of disease transmission. Artificial intelligence powered sensors and robotics support thermostable vaccine distribution in limited capacity regions, globally. Biosensors isolate COVID-19 vaccinations with low or limited efficacy. Finally, Vaccine 4.0 blockchain systems address low- and middle-income countries with limited distribution capacities. CONCLUSION Vaccine 4.0 is a viable framework to optimize manufacturing of vaccines during and post the COVID-19 pandemic.
Collapse
Affiliation(s)
- Azza Sarfraz
- Larkin Community Hospital, South Miami, FL, USA,The Aga Khan University, Karachi, Pakistan
| | - Zouina Sarfraz
- Larkin Community Hospital, South Miami, FL, USA,Fatima Jinnah Medical University, Lahore, Pakistan,Zouina Sarfraz, Division of Research & Academic Affairs, Larkin Community Hospital, 7031 SW 62nd Avenue, South Miami, FL 100181, USA.
| | - Muzna Sarfraz
- Larkin Community Hospital, South Miami, FL, USA,King Edward Medical University, Lahore, Pakistan
| | | | - Shehar Bano
- Fatima Jinnah Medical University, Lahore, Pakistan
| | | | | | - Trissa Paul
- Larkin Community Hospital, South Miami, FL, USA
| | | | | | - Miguel Felix
- Universidad Espiritu Santo, Samborondon, Ecuador,Respiralab Research Group, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espiritu Santo, Samborondon, Ecuador,Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
18
|
Sarfraz Z, Sarfraz A, Sarfraz M, Chohan FA, Stringfellow C, Jain E, Hange N, Loh H, Felix M, Cherrez-Ojeda I. Lessons learnt from emergency medicine services during the COVID-19 pandemic: A case study of India and the United States. Ann Med Surg (Lond) 2022; 73:103197. [PMID: 34956642 PMCID: PMC8690280 DOI: 10.1016/j.amsu.2021.103197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 12/09/2021] [Accepted: 12/18/2021] [Indexed: 12/02/2022] Open
Abstract
India and the United States have both witnessed a high burden of COVID-19 infections since the pandemic was declared in early 2020. However, the COVID-19 restrictions have met with mixed responses in India and the US. Despite recommendations to continue social isolation and personal hygiene measures, India has not been able to curb the rise in daily cases. Our findings demonstrate the difference in the manner by which India and the US differ in their emergency handling of patients. We conducted a thorough review of the existing protocols and data concerning emergency responses in India and the US. The triage and care of suspected COVID-19 positive patients is different across India and the US. We find that there is a shortage of oxygenation, vaccination and other essential supplies in India. Further, the US is able to triage patients through telemedicine and EMS before suspected COVID-19 patients arrive, which is less prevalent in India. Our study identifies the importance of the emergency department (ED) as a critical contributor to the prevention and care of suspected and confirmed COVID-19 patients. Hospitals in India have been struggling to accommodate a huge influx of patients during its second wave with the ED playing a key link in their COVID-19 response.
Collapse
Affiliation(s)
| | | | | | | | | | - Esha Jain
- Larkin Community Hospital, South Miami, FL, USA
| | | | - Hanyou Loh
- Larkin Community Hospital, South Miami, FL, USA
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
19
|
Felix M, Intriago Alvarez MB, Vanegas E, Farfán Bajaña MJ, Sarfraz Z, Sarfraz A, Michel J, Cherrez-Ojeda I. Risk of obstructive sleep apnea and traffic accidents among male bus drivers in Ecuador: Is there a significant relationship? Ann Med Surg (Lond) 2022; 74:103296. [PMID: 35145670 PMCID: PMC8818532 DOI: 10.1016/j.amsu.2022.103296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2021] [Revised: 01/17/2022] [Accepted: 01/22/2022] [Indexed: 11/18/2022] Open
Abstract
Background Obstructive sleep apnea (OSA) represents an important occupational health concern in the transportation industry, affecting a substantial percentage of transportation operators. Our study aims to determine the frequency of individuals at high risk of obstructive sleep apnea, and excessive daytime sleepiness, as well as any potential association between these conditions and traffic accidents among a sample of Ecuadorian bus drivers. Methods We conducted a cross-sectional study involving 340 commercial bus drivers from Ecuador. Descriptive statistics were used to determine frequency and proportions for demographic and clinical variables. A Kendall's tau-b was performed to ascertain the relationship between the STOP-Bang score towards the Epworth Sleepiness Scale (ESS) score and the number of accidents and near accidents. Results In general, 18.5% (n = 63) of participants were found to be at high-risk for OSA. There was a weak positive correlation between STOP-Bang score and ESS score (τb = 0.244, p = .000). We also found a statistically significant, although negligible, correlation between the STOP-Bang score and the number of accidents (τb = 0.096, p = .039) and near accidents (τb = 0.120, p = .008). Conclusion Our results suggest that a considerable proportion of Ecuadorian bus drivers were at high-risk for obstructive sleep apnea. Higher STOP-Bang scores were correlated with an increased number of accidents and near accidents. Additional studies are needed to determine whether additional interventions could increase road safety by taking care of undiagnosed and untreated OSA cases in a timely manner. Untreated obstructive sleep apnea is a significant contributor to motor vehicle crashes. The main consequence related to OSA is excessive daytime sleepiness, which is associated with increased risk of accidents. A considerable proportion of Ecuadorian bus drivers were at high-risk for obstructive sleep apnea. Higher STOP-Bang scores were correlated with an increased number of accidents and near accidents.
Collapse
|
20
|
Salman HM, Amin M, Syed J, Sarfraz Z, Sarfraz A, Sarfraz M, Farfán Bajaña MJ, Felix M, Cherrez-Ojeda I. Biochemical testing for the diagnosis of Wilson's disease: A systematic review. J Clin Lab Anal 2021; 36:e24191. [PMID: 34951059 PMCID: PMC8842170 DOI: 10.1002/jcla.24191] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Revised: 12/08/2021] [Accepted: 12/08/2021] [Indexed: 11/28/2022] Open
Abstract
Background Wilson's disease (WD) is a rare inherited disorder that leads to copper accumulation in the liver, brain, and other organs. WD is prevalent worldwide, with an occurrence of 1 per 30,000 live births. Currently, there is no gold standard diagnostic test for WD. The objective of this systematic review is to determine the diagnostic accuracy for WD of three biochemical tests, namely hepatic copper, 24‐hour urinary copper, and ceruloplasmin using the Leipzig criteria. Methods Adhering to PRISMA guidelines, databases including PubMed/MEDLINE, CINAHL Plus, Web of Science, and Cochrane were searched. Studies that comprised of confirmed or suspected WD along with normal populations were included with adult and pediatric group. The sensitivity, specificity, negative predictive value and positive predictive value were computed using RevMan 5.4. Results Nine studies were included. The best practice evidence for 24‐hour urinary copper test ranged from a cutoff value of 0.64–1.6 μmol/24 h (N = 268; sensitivity = 75.6%, specificity = 98.3%). Hepatic copper test was optimally cutoff based on the ROC curve analysis at 1.2 μmol/g yielding a power of 96.4% sensitivity and 95.4% specificity (N = 1,150); however, the tried and tested 4 μmol/g cutoff, with 99.4% sensitivity and 96.1% specificity, is more widely accepted. The ceruloplasmin test cutoff value was found to be ranging from 0.14 to 0.2 g/L (N = 4,281; sensitivity = 77.1%–99%, specificity = 55.9%–82.8%). Conclusion This paper provides a large‐scale analysis of current evidence pertaining to the biochemical diagnosis of WD employing the Leipzig criteria. The laboratory values are typically based on specific subgroups based on age, ethnicity, and clinical subgroups. The findings of this systematic review must be used with caution, given the over‐ or under‐estimation of the index tests.
Collapse
Affiliation(s)
| | - Mahwish Amin
- Sir Ganga Ram Hospital, Lahore, Punjab, Pakistan
| | | | | | | | | | - Maria Jose Farfán Bajaña
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
21
|
González-Balderas R, Velasquez-Orta S, Felix M, Bengoechea C, Yañez Noguez I, Orta Ledesma M. Identification and effect of ozone and ultrasound pretreatments on Desmodesmus sp. and Tetradesmus obliquus proteins. ALGAL RES 2021. [DOI: 10.1016/j.algal.2021.102514] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
22
|
Cherrez‐Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska‐Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, Van Doorn MBA, Rodrigues Valle SO, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez‐Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao Z, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Clin Transl Allergy 2021; 11:e12089. [PMID: 34962721 PMCID: PMC8684305 DOI: 10.1002/clt2.12089] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 12/03/2021] [Accepted: 12/07/2021] [Indexed: 11/21/2022] Open
Abstract
BACKGROUND Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self-evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global paucity of such apps for patients with CU. In this analysis, we assessed patient interest in using apps to monitor CU disease activity and control using questions from the chronic urticaria information and communication technologies (CURICT) study. METHODS The methodology for CURICT has been reported. Briefly, a 23-item questionnaire was completed by 1841 CU patients from 17 UCAREs across 17 countries. Here, we analyzed patient responses to the CURICT questions on the use of apps for urticaria-related purposes. RESULTS As previously published, the majority of respondents had chronic spontaneous urticaria (CSU; 63%; 18% chronic inducible urticaria (CIndU) [CIndu]; 19% with both), were female (70%) and in urban areas (75%). Over half of patients were very/extremely interested in an app to monitor disease activity (51%) and control (53%), while only ∼1/10 were not. Patients with both urticaria types versus those with CSU only (odds ratio [OR], 1.36 [1.03-1.79]) and females versus males (OR [95% CI], 1.47 [1.17-1.85]) were more likely to be very to extremely interested in an app to assess disease control. CONCLUSIONS Overall, half of the patients with CU were very to extremely interested in using an app to assess their disease activity and control. Development of well-designed apps, specific to disease types (CSU, CIndU, CSU + CIndU, etc), validated by experts across platforms would help improve the management and possibly outcomes of CU treatment while providing important patient information to be used in future research.
Collapse
Affiliation(s)
- Ivan Cherrez‐Ojeda
- Universidad Espíritu SantoSamborondónEcuador
- RespiralabRespiralab Research GroupGuayaquilEcuador
| | - Emanuel Vanegas
- Universidad Espíritu SantoSamborondónEcuador
- RespiralabRespiralab Research GroupGuayaquilEcuador
| | - Annia Cherrez
- RespiralabRespiralab Research GroupGuayaquilEcuador
- Clinic and Policlinic for Dermatology and VenereologyUniversity Medical Center RostockRostockGermany
| | - Miguel Felix
- Universidad Espíritu SantoSamborondónEcuador
- RespiralabRespiralab Research GroupGuayaquilEcuador
| | - Karsten Weller
- Institute for Allergology, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu BerlinBerlinGermany
- Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and ImmunologyBerlinGermany
| | - Markus Magerl
- Institute for Allergology, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu BerlinBerlinGermany
- Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and ImmunologyBerlinGermany
| | - Rasmus Robin Maurer
- Institute for Allergology, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu BerlinBerlinGermany
- Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and ImmunologyBerlinGermany
| | - Valeria L. Mata
- Universidad Espíritu SantoSamborondónEcuador
- RespiralabRespiralab Research GroupGuayaquilEcuador
| | - Alicja Kasperska‐Zajac
- European Center for Diagnosis and Treatment of UrticariaMedical University of SilesiaKatowicePoland
| | - Agnieszka Sikora
- European Center for Diagnosis and Treatment of UrticariaMedical University of SilesiaKatowicePoland
| | - Daria Fomina
- City Center of Allergy and ImmunologyClinical City Hospital #52MoscowRussia
- Department of Allergology and Clinical ImmunologyI.M. Sechenov First Moscow State Medical UniversityMoscowRussian Federation
| | - Elena Kovalkova
- City Center of Allergy and ImmunologyClinical City Hospital #52MoscowRussia
| | - Kiran Godse
- Department of DermatologyD Y, Patil University School of Medicine and HospitalMumbaiIndia
| | - Nimmagadda Dheeraj Rao
- Department of DermatologyD Y, Patil University School of Medicine and HospitalMumbaiIndia
| | - Maryam Khoshkhui
- Allergy Research CenterMashhad University of Medical SciencesMashhadIran
- Department of Allergy and ImmunologyMashhad University of Medical SciencesMashhadIran
| | - Sahar Rastgoo
- Department of Allergy and ImmunologyMashhad University of Medical SciencesMashhadIran
| | | | - Mohamed Abuzakouk
- Allergy and Immunology DepartmentCleveland Clinic Abu DhabiAbu DhabiUAE
| | - Deepa Grandon
- Allergy and Immunology DepartmentCleveland Clinic Abu DhabiAbu DhabiUAE
| | | | | | | | - Simon Francis Thomsen
- Department of DermatologyBispebjerg HospitalUniversity of Copenhagen, Biomedical SciencesCopenhagenDenmark
| | - German D. Ramón
- Instituto de Alergia e Inmunología del Sur, Bahía BlancaBuenos AiresArgentina
| | | | - Andrea Bauer
- Department of DermatologyUniversity Allergy CenterUniversity Hospital Carl Gustav CarusTechnical UniversityDresdenGermany
| | - Ana M. Giménez‐Arnau
- Department of DermatologyHospital del MarIMIM, Universitat AutònomaBarcelonaSpain
| | - Emek Kocatürk
- Department of DermatologyKoç University School of MedicineIstanbulTurkey
| | - Carole Guillet
- Department of DermatologyUniversity Hospital ZurichZurichSwitzerland
| | | | - Zuo‐Tao Zhao
- Department of Dermatology and VenereologyPeking University First HospitalBeijingChina
| | - Michael Makris
- Allergy Unit2nd Department of Dermatology and VenereologyNational and Kapodistrian University of Athens“Attikon” University HospitalAthensGreece
| | - Carla Ritchie
- Allergy DivisionHospital Italiano de Buenos AiresBuenos AiresArgentina
| | - Paraskevi Xepapadaki
- Allergy Department2nd Pediatric ClinicNational and Kapodistrian University of AthensAthensGreece
| | | | - Sofia Cherrez
- RespiralabRespiralab Research GroupGuayaquilEcuador
- Department of DermatologySRH Zentralklinikum SuhlSuhlGermany
| | - Marcus Maurer
- Institute for Allergology, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu BerlinBerlinGermany
- Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and ImmunologyBerlinGermany
| |
Collapse
|
23
|
Cherrez‐Ojeda I, Robles‐Velasco K, Osorio MF, Cottin V, Vergara Centeno J, Felix M. Follow-up of two cases of suspected interstitial lung disease following severe COVID-19 infection shows persistent changes in imaging and lung function. Clin Case Rep 2021; 9:e04918. [PMID: 34667604 PMCID: PMC8511883 DOI: 10.1002/ccr3.4918] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 08/25/2021] [Accepted: 09/25/2021] [Indexed: 11/14/2022] Open
Abstract
Physicians are observing persisting symptoms and unexpected organ dysfunction after severe COVID-19. In this report, we present the follow-up of two cases of suspected interstitial lung disease following the viral infection. Up to the last month of follow-up, both patients presented with persistent changes in imaging and pulmonary function tests.
Collapse
Affiliation(s)
- Ivan Cherrez‐Ojeda
- Universidad Espíritu SantoSamborondónEcuador
- Respiralab Research GroupGuayaquilEcuador
| | | | | | - Vincent Cottin
- National Coordinating Reference Center for Rare Pulmonary DiseasesLouis Pradel HospitalHospices Civils de LyonClaude Bernard University LyonLyonFrance
| | - José Vergara Centeno
- Universidad Espíritu SantoSamborondónEcuador
- Hospital General Guasmo SurGuayaquilEcuador
| | - Miguel Felix
- Universidad Espíritu SantoSamborondónEcuador
- Respiralab Research GroupGuayaquilEcuador
| |
Collapse
|
24
|
Cherrez-Ojeda I, Maurer M, Felix M, Bernstein JA, Ramon GD, Jardim Criado RF, Mata VL, Cherrez A, Morfin-Maciel BM, Larco JI, Tinoco IO, Chorzepa GF, Gómez RM, Raad RJ, Thomsen SF, Schmid-Grendelmeier P, Guillet C, Cherrez S, Vanegas E. "Chronic urticaria and obstructive sleep apnea: Is there a significant association?". World Allergy Organ J 2021; 14:100577. [PMID: 34471460 PMCID: PMC8387911 DOI: 10.1016/j.waojou.2021.100577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 06/07/2021] [Accepted: 08/03/2021] [Indexed: 11/28/2022] Open
Abstract
Background Few studies have explored the association between obstructive sleep apnea (OSA) and chronic urticaria (CU). Our study aims to fill this gap by determining the frequency of the risk categories for OSA and how they might correlate with the specific CU patient reported outcome measures urticaria activity score (UAS7), urticaria control test (UCT) and CU quality of life questionnaire (CU-Q2oL). Methods We conducted a cross-sectional study involving a cohort of 171 Latin American CU patients. Descriptive statistics were used to determine frequency and proportions for demographic and clinical variables, while a chi-squared test for association between STOP-Bang OSA questionnaire categories and both UAS7 and UCT categories was performed to analyze how such variables interact. To further assess the strength of the correlation a Cramer's V coefficient was reported. Finally, a Kendall-Tau b correlation coefficient was performed to measure the correlation between the STOP-Bang score and other independent continuous variables. Results The average STOP-Bang score was 2.5, with 24% and 21% of patients falling into the intermediate and high-risk category for moderate-to-severe OSA, respectively. There was a strong statistically significant association (Cramer's V = 0.263; p = .000) between UAS-7 categories and STOP-Bang risk categories. A similar pattern of strong significant association (Cramer's V = .269; p = .002) was observed between UCT categories and STOP-Bang risk categories. A weak positive correlation between the STOP-Bang score and the CU-Q2oL average score (τb = 0.188, p = .001) was identified. Overall, 72.5% patients reported limitations with respect to sleep in a varied degree according to the CU-Q2oL. Conclusions Our results suggest that a considerable proportion of patients with CU are at intermediate to high risk for OSA. Higher disease activity, poor CU control, and worse quality of life were all found to be associated with an increased risk. Additional studies are needed to determine the exact link between these conditions, and to determine whether screening and treatment for OSA might benefit patients with CU.
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Marcus Maurer
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Jonathan A Bernstein
- University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Immunology/Allergy Section, Cincinnati, OH, United States
| | - German D Ramon
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Argentina
| | | | - Valeria L Mata
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Annia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany
| | | | | | | | | | | | - Rodolfo Jaller Raad
- Departamento de Alergias del Centro de Asma Alergia e Inmunología Barranquilla, Colombia
| | - Simon Francis Thomsen
- Department of Dermatology, Bispebjerg Hospital and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
| | | | - Carole Guillet
- Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.,Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Sofia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,Department of Dermatology, SRH Zentralklinikum Suhl, Germany
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
25
|
Arif A, Bhinder KK, Sarfraz A, Sarfraz Z, Felix M, Chérrez-Ojeda I. The radiological presentation of Rasmussen aneurysm secondary to pulmonary tuberculosis and COVID-19: A case report. Radiol Case Rep 2021; 16:3350-3353. [PMID: 34377220 PMCID: PMC8343381 DOI: 10.1016/j.radcr.2021.07.088] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2021] [Revised: 07/29/2021] [Accepted: 07/31/2021] [Indexed: 11/19/2022] Open
Abstract
Rasmussen aneurysm is rare diagnosis occurring in patients with long-standing tuberculosis. TB-COVID-19 co-infection in the context of Rasmussen aneurysm is a rare occurrence, yet new cases are emerging. An elderly male was recently diagnosed with TB-COVID-19 co-infection and presented with sudden onset massive hemoptysis. The patient was diagnosed with Rasmussen aneurysm after being evaluated by computed tomography pulmonary angiogram due to a suggestive clinical presentation. Interventional radiologists planned for embolization of pulmonary artery, with an unidentifiable source. It was suspected that the patient's source of bleeding was hampered due to local tamponade effect or thrombosis of the aneurysm. The patient remained stable after 24 hours on computed tomography pulmonary angiogram. Our case emphasizes the importance of Rasmussen aneurysm as a differential diagnosis when presented with a TB-COVID-19 co-infection and sudden onset of hemoptysis symptomatically and radiologically. The timely diagnosis and management are key to improve mortality.
Collapse
Affiliation(s)
- Adnan Arif
- Shifa International Hospital, Islamabad, Pakistan
| | | | | | - Zouina Sarfraz
- Fatima Jinnah Medical University, Lahore, Pakistan
- Corresponding author.
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Center, Guayaquil, Ecuador
| | - Ivan Chérrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab Research Center, Guayaquil, Ecuador
| |
Collapse
|
26
|
Cherrez-Ojeda I, Vanegas E, Cherrez A, Felix M, Weller K, Magerl M, Maurer RR, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RF, Abuzakouk M, Grandon D, Van Doorn MBA, Oliveira Rodrigues Valle S, De Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Larco JI, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Maurer M. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ J 2021; 14:100542. [PMID: 34141048 PMCID: PMC8190491 DOI: 10.1016/j.waojou.2021.100542] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Revised: 03/26/2021] [Accepted: 04/09/2021] [Indexed: 11/03/2022] Open
Abstract
Background Patients with chronic urticaria (CU) are increasingly using information and communication technologies (ICTs) to manage their health. What CU patients expect from ICTs and which ICTs they prefer remains unknown. We assessed why CU patients use ICTs, which ones they prefer, and what drives their expectations and choices. Methods In this cross-sectional study, 1841 patients across 17 countries were recruited at UCAREs (Urticaria Centers of Reference and Excellence). Patients with CU who were >12 years old completed a 23-item questionnaire. Results Most patients were interested in receiving disease information (87.3%), asking physicians about CU (84.1%), and communicating with other patients through ICTs (65.6%). For receiving disease information, patients preferred one-to-one and one-to-many ICTs, especially web browsers. One-to-one ICTs were also the ICTs of choice for asking physicians about urticaria and for communicating with other patients, and e-mail and WhatsApp were the preferred ICTs, respectively. Many-to-many ICTs such as Facebook, Instagram, LinkedIn, and Twitter were least preferred for all 3 purposes. Living in rural areas and higher education were linked to higher odds of being interested in receiving disease information, asking physicians, and communicating with patients through ICTs. Conclusions Most patients and especially patients with higher education who live in rural areas are interested in using ICTs for their healthcare, but prefer different ICTs for different purposes, ie, web browsers for obtaining information, e-mail for asking physicians, and WhatsApp for communicating with other patients. Our findings may help to improve ICTs for CU.
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Annia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Karsten Weller
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Markus Magerl
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Rasmus Robin Maurer
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Valeria L Mata
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Alicja Kasperska-Zajac
- European Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland
| | - Agnieszka Sikora
- European Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland
| | - Daria Fomina
- City Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia.,Department of Allergology and Clinical Immunology, I.M. Sechenov First Moscow State Medical University, Trubetskaya St., 8/2, Moscow, 119991, Russian Federation
| | - Elena Kovalkova
- City Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia
| | - Kiran Godse
- Department of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India
| | - Nimmagadda Dheeraj Rao
- Department of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India
| | - Maryam Khoshkhui
- Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Department of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Sahar Rastgoo
- Department of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Roberta Fj Criado
- Department of Dermatology, Faculdade de Medicina do ABC, São Paulo, Brazil
| | - Mohamed Abuzakouk
- Allergy and Immunology Department, Cleveland Clinic Abu Dhabi, United Arab Emirates
| | - Deepa Grandon
- Allergy and Immunology Department, Cleveland Clinic Abu Dhabi, United Arab Emirates
| | | | | | | | - Simon Francis Thomsen
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Biomedical Sciences, Copenhagen, Denmark
| | - German D Ramón
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Prov. De Buenos Aires, Argentina
| | - Edgar E Matos Benavides
- Centro de Referencia de Alergia, Asma e Inmunología - Instituto Nacional del Niño, Lima, Perú
| | - Andrea Bauer
- Department of Dermatology, University Allergy Center, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany
| | - Ana M Giménez-Arnau
- Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma, Barcelona, Spain
| | - Emek Kocatürk
- Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey
| | - Carole Guillet
- Department of Dermatology, University Hospital Zurich, Switzerland
| | | | - Zuo-Tao Zhao
- Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China
| | - Michael Makris
- Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian, University of Athens, "Attikon" University Hospital, Greece
| | - Carla Ritchie
- Allergy Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Paraskevi Xepapadaki
- Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Greece
| | | | - Sofia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,Department of Dermatology, SRH Zentralklinikum Suhl, Germany
| | - Marcus Maurer
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| |
Collapse
|
27
|
Felix M, Vera Paz C, Mata VL, Vanegas E, Larenas-Linnemann D, Rosario NA, Letort J, Cherrez-Ojeda I. Perceptions and Management of Allergic Rhinitis Among Ecuadorian Otorhinolaryngologists: A Survey-Based Study. J Multidiscip Healthc 2020; 13:1975-1981. [PMID: 33364779 PMCID: PMC7751582 DOI: 10.2147/jmdh.s269531] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Accepted: 11/03/2020] [Indexed: 01/10/2023] Open
Abstract
Objective Allergic rhinitis (AR) represents a large burden to the healthcare system due to its high prevalence and impact on patients’ lives. Despite the existence of evidence-based guidelines, some studies have found that physicians do not always follow the latest recommendations. The aim of our study was to determine how Ecuadorian otorhinolaryngologists (ENTs) perceive some epidemiological aspects related to AR, as well as their preferences for managing the disease. Methods We conducted an observational, survey-based cross-sectional study, among 116 Ecuadorian ENTs. The survey used was adapted from a previous publication and consisted of 30 multiple choice questions, concerning several topics of AR. Descriptive statistics (frequency, and standard deviation) were performed for clinical and demographic variables. Results A total of 116 Ecuadorian ENTs completed the survey. Of them, 62.9% were male, with an average age of 42 years (SD ± 11.58). Computed tomography (CT) scan and nasal cytology were selected as the main diagnostic tests for AR by 62/91 (68.1%) and 45/91 (49.5%) of participants, respectively. Moreover, only 12/116 (10.3%) of participants performed skin prick tests (SPT). Allergen immunotherapy (AIT) was performed by 37/107 (36.4%) of participants. Conclusion In general, most participants agreed that the prevalence of AR appears to be increasing, with increased exposure to allergens, irritants, and pollutants as the main probable cause. Children and adolescents were accounted as the group most affected by AR, with sinusitis and asthma identified as the most frequent comorbidities. Finally, we found unmet needs in the diagnostic and management of AR that should be addressed among Ecuadorian ENTs, in particular the high use of CT scans as part of routine evaluations, as well as the low use of allergen immunotherapy.
Collapse
Affiliation(s)
- Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,RespiraLab Research Group, Guayaquil, Ecuador
| | - Carlos Vera Paz
- Universidad Espíritu Santo, Samborondón, Ecuador.,RespiraLab Research Group, Guayaquil, Ecuador
| | - Valeria L Mata
- Universidad Espíritu Santo, Samborondón, Ecuador.,RespiraLab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,RespiraLab Research Group, Guayaquil, Ecuador
| | | | - Nelson A Rosario
- Departamento de Pediatria, Universidade Federal do Parana, Curitiba, Brazil
| | - Jose Letort
- Departamento de Otorrinolaringología, Hospital, Quito, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,RespiraLab Research Group, Guayaquil, Ecuador
| |
Collapse
|
28
|
Chérrez-Ojeda I, Vanegas E, Felix M. The unusual experience of managing a severe COVID-19 case at home: what can we do and where do we go? BMC Infect Dis 2020; 20:862. [PMID: 33213364 PMCID: PMC7675380 DOI: 10.1186/s12879-020-05608-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Accepted: 11/10/2020] [Indexed: 12/15/2022] Open
Abstract
Background The speed and reach of the COVID-19 pandemic has created special scenarios to be considered, such as those in where patients who meet criteria for hospitalization due to moderate/severe disease cannot be hospitalized due to economic constraints and saturation of national health systems. The aim of this report is to present an unusual case of a severe COVID-19 patient managed at home in a developing country, and to discuss some of the available guidelines and potential therapeutic options for this type of cases. Case presentation A 60-year-old female seeking medical attention through teleconsultation presents with profound dyspnea, oppressive chest pain, fatigue, episodic hallucinations, and difficulty sleeping, for what she originally sought medical attention at an ER but could not be admitted due to saturation of the health system. A positive PCR test for COVID-19, and a CT scan of the chest showing bilateral consolidations with ground-glass opacities confirmed the diagnosis. The patient was managed at home, with corticosteroids, nitazoxanide and a single dose of 40 mg of subcutaneous enoxaparin. Colchicine was added at the third day of treatment. Standard oxygen therapy through nasal cannula was also recommended. Daily follow-ups were established to monitor for signs of clinical improvement. Two weeks later from the initial consultation the patient presents marked improvement in her symptoms, as well as in her CT scan, which prompted in discontinuation of the medications and the oxygen therapy. Conclusions There are several limitations in this report regarding the clinical data and the management, but such limitations do also reflect the state of emergency and the chaos that resides in the health care systems of developing nations. For the ambulatory care of COVID-19 patients, several aspects of disease management may differ from current guidelines and basic requirements may represent a huge challenge to cover. Further research is needed to assist physicians in the daily clinical decision making, to optimize patient outcomes, and to reduce the probability of adverse scenarios of patients with COVID-19 managed in the ambulatory setting.
Collapse
Affiliation(s)
- Ivan Chérrez-Ojeda
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952, Samborondón, Ecuador. .,Respiralab Research Group, Guayaquil, Ecuador.
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, 0901-952, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
29
|
Alonso-González M, Corral-González A, Felix M, Romero A, Martin-Alfonso J. Developing active poly(vinyl alcohol)-based membranes with encapsulated antimicrobial enzymes via electrospinning for food packaging. Int J Biol Macromol 2020; 162:913-921. [DOI: 10.1016/j.ijbiomac.2020.06.217] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Revised: 06/04/2020] [Accepted: 06/24/2020] [Indexed: 01/16/2023]
|
30
|
Maurer M, Weller K, Magerl M, Maurer RR, Vanegas E, Felix M, Cherrez A, Mata VL, Kasperska-Zajac A, Sikora A, Fomina D, Kovalkova E, Godse K, Rao ND, Khoshkhui M, Rastgoo S, Criado RFJ, Abuzakouk M, Grandon D, van Doorn M, Valle SOR, de Souza Lima EM, Thomsen SF, Ramón GD, Matos Benavides EE, Bauer A, Giménez-Arnau AM, Kocatürk E, Guillet C, Ignacio Larco J, Zhao ZT, Makris M, Ritchie C, Xepapadaki P, Ensina LF, Cherrez S, Cherrez-Ojeda I. The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study. World Allergy Organ J 2020; 13:100475. [PMID: 33204387 PMCID: PMC7606865 DOI: 10.1016/j.waojou.2020.100475] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Revised: 09/10/2020] [Accepted: 09/24/2020] [Indexed: 11/04/2022] Open
Abstract
Background Chronic urticaria (CU) is characterized by itchy recurrent wheals, angioedema, or both for 6 weeks or longer. CU can greatly impact patients' physical and emotional quality of life. Patients with chronic conditions are increasingly seeking information from information and communications technologies (ICTs) to manage their health. The objective of this study was to assess the frequency of usage and preference of ICTs from the perspective of patients with CU. Methods In this cross-sectional study, 1800 patients were recruited from primary healthcare centers, university hospitals or specialized clinics that form part of the UCARE (Urticaria Centers of Reference and Excellence) network throughout 16 countries. Patients were >12 years old and had physician-diagnosed chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CIndU). Patients completed a 23-item questionnaire containing questions about ICT usage, including the type, frequency, preference, and quality, answers to which were recorded in a standardized database at each center. For analysis, ICTs were categorized into 3 groups as follows: one-to-one: SMS, WhatsApp, Skype, and email; one-to-many: YouTube, web browsers, and blogs or forums; many-to-many: Instagram, Twitter, Facebook, and LinkedIn. Results Overall, 99.6% of CU patients had access to ICT platforms and 96.7% had internet access. Daily, 85.4% patients used one-to-one ICT platforms most often, followed by one-to-many ICTs (75.5%) and many-to-many ICTs (59.2%). The daily ICT usage was highest for web browsers (72.7%) and WhatsApp (70.0%). The general usage of ICT platforms increased in patients with higher levels of education. One-to-many was the preferred ICT category for obtaining general health information (78.3%) and for CU-related information (75.4%). A web browser (77.6%) was by far the most commonly used ICT to obtain general health information, followed by YouTube (25.8%) and Facebook (16.3%). Similarly, for CU-specific information, 3 out of 4 patients (74.6%) used a web browser, 20.9% used YouTube, and 13.6% used Facebook. One in 5 (21.6%) patients did not use any form of ICT for obtaining information on CU. The quality of the information obtained from one-to-many ICTs was rated much more often as very interesting and of good quality for general health information (53.5%) and CU-related information (51.5%) as compared to the other categories. Conclusions Usage of ICTs for health and CU-specific information is extremely high in all countries analyzed, with web browsers being the preferred ICT platform.
Collapse
Key Words
- (3–5) ICT
- Apps, applications
- CIndU, chronic inducible urticaria
- CSU, chronic spontaneous urticaria
- CU, chronic urticaria
- HCP, healthcare provider
- ICT, information and communications technologies
- Information and communications technology
- SEM, self-management education
- SMS, short messaging service
- Self-management
- UAE, United Arab Emirates
- UCARE, Urticaria Centers of Reference and Excellence
- Urticaria
Collapse
Affiliation(s)
- Marcus Maurer
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Karsten Weller
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Markus Magerl
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Rasmus Robin Maurer
- Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Annia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany
| | - Valeria L Mata
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Alicja Kasperska-Zajac
- European Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland
| | - Agnieszka Sikora
- European Center for Diagnosis and Treatment of Urticaria, Medical University of Silesia, Katowice, Poland
| | - Daria Fomina
- City Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia.,Department of Allergology and Clinical Immunology, I.M. Sechenov First Moscow State Medical University, Trubetskaya St., 8/2, Moscow, 119991, Russian Federation
| | - Elena Kovalkova
- City Center of Allergy and Immunology, Clinical City Hospital #52, Moscow, Russia
| | - Kiran Godse
- Department of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India
| | - Nimmagadda Dheeraj Rao
- Department of Dermatology, D Y, Patil University School of Medicine and Hospital, Mumbai, India
| | - Maryam Khoshkhui
- Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Department of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Sahar Rastgoo
- Department of Allergy and Immunology, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Mohamed Abuzakouk
- Allergy and Immunology Department, Cleveland Clinic Abu Dhabi, The Uae
| | - Deepa Grandon
- Allergy and Immunology Department, Cleveland Clinic Abu Dhabi, The Uae
| | | | | | | | - Simon Francis Thomsen
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Biomedical Sciences, Copenhagen, Denmark
| | - German D Ramón
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, De Buenos Aires, Argentina
| | - Edgar E Matos Benavides
- Centro de Referencia de Alergia, Asma e Inmunología - Instituto Nacional del Niño, Lima-Perú
| | - Andrea Bauer
- Department of Dermatology, University Allergy Center, University Hospital Carl Gustav Carus, Technical University, Dresden, Germany
| | | | - Emek Kocatürk
- Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey
| | - Carole Guillet
- Department of Dermatology, University Hospital Zurich, Switzerland
| | | | - Zuo-Tao Zhao
- Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China
| | - Michael Makris
- Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, "Attikon" University Hospital, Greece
| | - Carla Ritchie
- Allergy Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| | - Paraskevi Xepapadaki
- Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Greece
| | | | - Sofia Cherrez
- Department of Dermatology, SRH Zentralklinikum Suhl, Germany.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
31
|
Sabando Vélez BE, Plaza Meneses C, Felix M, Vanegas E, Mata VL, Romero Castillo H, Oliveros Alvear JW, Boloña E, Alejandra Posligua M, Layedra Bardi LR, Vera Paz C, Cherrez-Ojeda I. A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries. J Infect Dev Ctries 2020; 14:737-741. [PMID: 32794463 DOI: 10.3855/jidc.12827] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Accepted: 06/22/2020] [Indexed: 10/31/2022] Open
Abstract
The COVID-19 pandemic has affected 187 countries, representing a global public health problem. The increasing number of critically ill patients and deaths have fueled a desperate search for treatments that can halt the course of the disease. Currently, there are several experimental therapies with demonstrated in vitro activity against COVID-19 used in clinical practice, including hydroxychloroquine, remdesivir, interleukin-6 pathway inhibitors, and convalescent plasma; however, to date no agent has proven efficacy against COVID-19. In the case of convalescent plasma, this therapy consists in obtaining neutralizing antibodies from previously infected individuals by plasmapheresis and administering them to patients with severe disease. Recently, the use of convalescent plasma has shown promising results in preliminary studies, with case series reporting a decrease in temperature, and viral load, as well as improvement in clinical parameters among patients receiving this treatment. However, there are still unmet needs regarding the safety profile, tolerability, dosage, and timing this therapy should be given. Based on this, the objective of our study was to develop and propose a practical approach for the compassionate use of convalescent plasma for the treatment of patients with severe COVID-19, given the constrains and limitations of developing countries. We encourage health professionals in developing countries to use the current evidence and approaches to experimental treatments for patients with COVID-19, adapting them to their conditions, and always based on a thorough risk-benefit evaluation for each patient, and whenever possible to design and promote the much needed research in this field.
Collapse
Affiliation(s)
| | | | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Ramon GD, Vanegas E, Felix M, Barrionuevo LB, Kahn AM, Bertone M, Reyes MS, Gaviot S, Ottaviano C, Cherrez-Ojeda I. Year-long trends of airborne pollen in Argentina: More research is needed. World Allergy Organ J 2020; 13:100135. [PMID: 32670462 PMCID: PMC7348068 DOI: 10.1016/j.waojou.2020.100135] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2020] [Revised: 05/18/2020] [Accepted: 05/19/2020] [Indexed: 11/29/2022] Open
Affiliation(s)
- German D Ramon
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Argentina.,Asociación Argentina de Alergia e Inmunología Clínica, Bahía Blanca Pollen Station, Argentina
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | | | - Adrian M Kahn
- Hospital Privado Universitario de Córdoba, Argentina.,Instituto Universitario de Ciencias Biomédicas de Córdoba, Argentina.,Asociación Argentina de Alergia e Inmunología Clínica, Córdoba Pollen Station, Argentina
| | | | - Maria Sol Reyes
- Asociación Argentina de Alergia e Inmunología Clínica, Bariloche Pollen Station, Argentina
| | - Solange Gaviot
- Asociación Argentina de Alergia e Inmunología Clínica, Santa Rosa Pollen Station, Argentina
| | | | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
33
|
Boloña E, Felix M, Vanegas E, Vera Paz C, Cherrez-Ojeda I. A Case of Vaping-associated Pulmonary Illness in South America: Highlighting the Need for Awareness and Surveillance Programs in the Region. Am J Respir Crit Care Med 2020; 201:733-735. [PMID: 31810372 PMCID: PMC7068832 DOI: 10.1164/rccm.201910-2002le] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Enrique Boloña
- Clínica GuayaquilGuayaquil, Ecuador.,Universidad Espíritu SantoSamborondón, Ecuadorand
| | - Miguel Felix
- Universidad Espíritu SantoSamborondón, Ecuadorand.,Respiralab Research GroupGuayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu SantoSamborondón, Ecuadorand.,Respiralab Research GroupGuayaquil, Ecuador
| | - Carlos Vera Paz
- Universidad Espíritu SantoSamborondón, Ecuadorand.,Respiralab Research GroupGuayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu SantoSamborondón, Ecuadorand.,Respiralab Research GroupGuayaquil, Ecuador
| |
Collapse
|
34
|
Vanegas E, Felix M, Ramon GD, López Jove O, Matos Benavides EE, Tinoco-Morán I, Bernstein JA, Cherrez-Ojeda I. Influence of alexithymia on the management of Latin American patients with asthma: A cross-sectional study. SAGE Open Med 2020; 8:2050312120930913. [PMID: 32551114 PMCID: PMC7278303 DOI: 10.1177/2050312120930913] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Accepted: 05/11/2020] [Indexed: 11/17/2022] Open
Abstract
Objectives: In asthmatic patients, studies suggest that alexithymia leads to negative consequences and emotions that can affect physical, psychological, and social aspects of life. We designed this study to determine the frequency of alexithymia in Latin American patients with asthma, as well as to understand how this personality trait and each of its components interact with asthma severity and demographic variables, and their implications on treatment adherence and disease control under such setting. Methods: We conducted a cross-sectional study, involving 265 Latin American patients with asthma. Patient demographics and clinical characteristics were reported. The presence of alexithymia, asthma severity, and control, as well as treatment adherence, was analyzed. To assess the presence of alexithymia, the 20-item Toronto Alexithymia Scale was used. For the statistical analyses, we performed Kendall’s tau-b correlation coefficient, chi-square tests for association, and one-way analysis of variance. Results: A total of 265 patients participated in the study with a gender distribution of 69.4% female and an average age of 54.7 years. In total, 30.2% of individuals presented alexithymia. There was a statistically significant correlation between educational level and 20-item Toronto Alexithymia Scale categories (p < .001), as well as a higher proportion of severe (35.1%, p = .001) and uncontrolled (50.0%, p = .185) asthma in patients with alexithymia. A higher proportion of patients with some level of non-adherence was seen on those with uncontrolled asthma (68.5%, p = .008). Conclusion: Our results suggest that in our sample, 3 in 10 Latin American asthma patients have alexithymia, and such mental condition is more common in those individuals with lower educational levels. Individuals with alexithymia present with severe asthma more frequently than do patients with possible or no alexithymia and are also more likely to have their disease uncontrolled.
Collapse
Affiliation(s)
- Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - German D Ramon
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Argentina
| | - Orlando López Jove
- Servicio de Neumología Clínica, Hospital Zonal Especializado de Agudos y Crónicos "Dr. Antonio Cetrángolo," Buenos Aires, Argentina
| | | | | | - Jonathan A Bernstein
- Division of Immunology/Allergy Section, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA
| | - Iván Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
35
|
Felix M, Brom de Luna J, Hinrichs K. A swim-over technique for sperm preparation for production of blastocysts by ICSI. J Equine Vet Sci 2020. [DOI: 10.1016/j.jevs.2020.103034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
36
|
Chérrez-Ojeda I, Vera C, Vanegas E, Gallardo JC, Felix M, Espinoza-Fuentes F, Chedraui P, Gavilanes AWD, Mata VL. The use of information and communication technologies in Latin American dentists: a cross-sectional study from Ecuador. BMC Oral Health 2020; 20:146. [PMID: 32429887 PMCID: PMC7236194 DOI: 10.1186/s12903-020-01137-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Accepted: 05/11/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The use of information and communication technologies (ICTs) provide the tools for enabling fast and reliable real-time communications, as well as the transfer of information between dental professionals and their patients. However, little is known about the frequency and preference of ICTs among Latin-American dentists. Our study aims to fill this gap by assessing different aspects related to ICTs, mainly the frequency of use, perceptions, and barriers among Ecuadorian dentists. METHODS An anonymous, cross-sectional survey-based study was conducted among 342 Ecuadorian dentists. The final questionnaire included 13 items related to the frequency of use, perceptions, and barriers of ICTs. Bivariate analysis was performed by using chi-squared testing to explore the association between the independent variables and the intended use of ICTs, as well as to characterize the perceptions and barriers related to ICTs. RESULTS In general, most participants reported the use of ICTs to communicate with colleagues (99.7%), and patients (96.2%), while only 63.5% reported using ICTs to obtain academic information in their daily practice. WhatsApp was rated as the most used ICT for communicating with colleagues and patients. A majority of participants considered that ICTs can be useful for facilitating continuing dental education (92.1%), searching new work opportunities (91.5%), promoting health (90.1%), working with colleagues and other health professionals (91.2%), promoting their professional services (90.6%), and for resolving clinical cases (87.7%). On the subject of barriers, privacy and security concerns about personal and/or patient information was the biggest concern among dentists (65%), followed by lack of time to learn how to use and/or use ICTs (48%), lack of mobile internet access (28.1%), and lack of internet access at work (24.9%). CONCLUSION In our study, we found that Ecuadorian dentists had a high usage rate of ICTs, mainly for communicating with other colleagues and patients, while the academic use of technology remains a comparatively underused application. Most of the participants surveyed had a positive perception towards ICTs, while privacy and security concerns were identified as the main barrier. Older age was associated with a less favourable perception toward ICTs, as well as an increased likelihood of reporting barriers related to the use of technology.
Collapse
Affiliation(s)
- Ivan Chérrez-Ojeda
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Zip code: 0901-952, Samborondón, Ecuador. .,Respiralab Research Group, Guayaquil, Ecuador.
| | - Carlos Vera
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Zip code: 0901-952, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Zip code: 0901-952, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Juan Carlos Gallardo
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Zip code: 0901-952, Samborondón, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Zip code: 0901-952, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | | | - Peter Chedraui
- Facultad De Ciencias Médicas, Instituto De Investigación e Innovación En Salud Integral, Universidad Católica De Santiago De Guayaquil, Guayaquil, Ecuador.,Facultad De Ciencias De La Salud, Universidad Católica "Nuestra Señora De La Asunción", Asunción, Paraguay
| | - Antonio W D Gavilanes
- School of Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.,Department of Pediatrics, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Valeria L Mata
- Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Zip code: 0901-952, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| |
Collapse
|
37
|
Cherrez-Ojeda I, Vanegas E, Felix M, Mata VL, Jiménez FM, Sanchez M, Simancas-Racines D, Cherrez S, Gavilanes AWD, Eschrich J, Chedraui P. Frequency of Use, Perceptions and Barriers of Information and Communication Technologies Among Latin American Physicians: An Ecuadorian Cross-Sectional Study. J Multidiscip Healthc 2020; 13:259-269. [PMID: 32214821 PMCID: PMC7082627 DOI: 10.2147/jmdh.s246253] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Accepted: 02/27/2020] [Indexed: 01/13/2023] Open
Abstract
Objective In recent years, the use of information and communication technologies (ICTs) has increased in various sectors, among which the healthcare service is no exception. However, studies have mostly focused on the use of ICTs among patients with chronic diseases, with few reports on the advantages and barriers of these technologies among physicians, particularly in Latin America. We designed this study to fill in the gap, as an objective assessment of the frequency of use, perceptions, and barriers of ICTs among physicians remains crucial for a successful implementation of these technologies into the mainstream medical practice. Methods We conducted an anonymous cross-sectional survey-based study in 640 Ecuadorian physicians. The survey used consisted of 13 items and evaluated the frequency of use, perceptions, and barriers of ICTs among physicians. Chi-square tests for goodness of fit and independence were performed, whilst Phi coefficient was interpreted to assess the strength of associations. Fisher exact test was performed when required. Results Over 90% of physicians reported the use of ICTs to message other colleagues and patients (p=0.000). While 89.5% of physicians used social media to interact with other colleagues, only 58.1% used them to interact with patients (p=0.000). Most participants reported the use of ICTs to search for academic information (p=0.000). Moreover, more than 80.0% agree that ICTs may be used to promote health and medical services, search new job opportunities, get involved in research projects and promote teamwork with colleagues. However, 83.6% of physicians expressed concerns about privacy and patient confidentiality, while 53.8% stated that they lacked the time to use ICTs. Conclusion High usage of ICTs was found among Ecuadorian physicians. Younger physicians, with less postgraduate years, and non-specialists were more likely to have a positive perception toward ICTs. Privacy and patient confidentiality, followed by time management, were the most reported barriers in our study.
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respira Lab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respira Lab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respira Lab Research Group, Guayaquil, Ecuador
| | - Valeria L Mata
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respira Lab Research Group, Guayaquil, Ecuador
| | - Fanny M Jiménez
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respira Lab Research Group, Guayaquil, Ecuador
| | - Mabel Sanchez
- Universidad Laica Eloy Alfaro, Manabí, Ecuador.,Universidad Estatal Del Sur Del Manabí, Manabí, Ecuador
| | - Daniel Simancas-Racines
- Centro De Investigación En Salud Pública y Epidemiología Clínica, Facultad De Ciencias De La Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, Ecuador
| | - Sofia Cherrez
- School of Medicine, University of Heidelberg, Heidelberg, Germany
| | - Antonio W D Gavilanes
- Department of Pediatrics, Maastricht University Medical Center, Maastricht, the Netherlands.,School of Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands
| | | | - Peter Chedraui
- Instituto De Investigación e Innovación En Salud Integral, Facultad De Ciencias Médicas, Universidad Católica De Santiago De Guayaquil, Guayaquil, Ecuador.,Facultad De Ciencias De La Salud, Universidad Católica "Nuestra Señora De La Asunción", Asunción, Paraguay
| |
Collapse
|
38
|
Chérrez-Ojeda I, Felix M, Mata VL, Vanegas E, Simancas-Racines D, Aguilar M, Gavilanes AWD, Chedraui P, Vera C. Use and Perceptions of Information and Communication Technologies Among Ecuadorian Nurses: A Cross-sectional Study. Open Nurs J 2020. [DOI: 10.2174/1874434602014010001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Background:
Nurses represent a key group for the implementation of Information and Communication Technologies (ICTs), however, few studies have explored the current use of these technologies among healthcare professionals in developing countries. Our study aims to achieve a better understanding of how Ecuadorian nurses perceive the theoretical advantages and limitations of ICTs, as well as to explore the current use of these technologies in the setting of the professional nursing practice.
Methods:
We conducted an anonymous survey-based cross-sectional study where 191 nurses rated their frequency of use and level of agreement to specific statements on perceptions related to ICTs. For the statistical analyses, adjusted binomial logistic regressions and the chi-squared test for association were applied.
Results:
In general, 96.3% of nurses reported the use of ICTs to communicate with colleagues, and 80.1% reported the use of ICTs to communicate with patients. More than 70% of participants agreed that ICTs can be useful to promote professional services, help in the search for new job opportunities and/or professional development, foster health promotion, and improve the workflow with colleagues. Meanwhile, 78.6% of nurses had privacy or security concerns about personal and/or patient information, and 60.6% reported not having enough time neither to learn how to use ICTs nor to use them.
Conclusion:
High use of ICTs was found among Ecuadorian nurses for communicating with both colleagues and patients. Most of the participants had a positive perception of the use of ICTs in the healthcare practice, particularly among younger nurses. Finally, the major reservations perceived were related to privacy and patient confidentiality, and lack of time to learn how to use, or use ICTs.
Collapse
|
39
|
Chérrez-Ojeda I, Felix M, Mata VL, Vanegas E, Simancas-Racines D, Aguilar M, Gavilanes AWD, Chedraui P, Vera C. Use and Perceptions of Information and Communication Technologies Among Ecuadorian Nurses: A Cross-sectional Study. Open Nurs J 2020. [DOI: 10.2174/1874434602014010008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Background:
Nurses represent a key group for the implementation of Information and Communication Technologies (ICTs), however, few studies have explored the current use of these technologies among healthcare professionals in developing countries. Our study aims to achieve a better understanding of how Ecuadorian nurses perceive the theoretical advantages and limitations of ICTs, as well as to explore the current use of these technologies in the setting of the professional nursing practice.
Methods:
We conducted an anonymous survey-based cross-sectional study where 191 nurses rated their frequency of use and level of agreement to specific statements on perceptions related to ICTs. For the statistical analyses, adjusted binomial logistic regressions and the chi-squared test for association were applied.
Results:
In general, 96.3% of nurses reported the use of ICTs to communicate with colleagues, and 80.1% reported the use of ICTs to communicate with patients. More than 70% of participants agreed that ICTs can be useful to promote professional services, help in the search for new job opportunities and/or professional development, foster health promotion, and improve the workflow with colleagues. Meanwhile, 78.6% of nurses had privacy or security concerns about personal and/or patient information, and 60.6% reported not having enough time neither to learn how to use ICTs nor to use them.
Conclusion:
High use of ICTs was found among Ecuadorian nurses for communicating with both colleagues and patients. Most of the participants had a positive perception of the use of ICTs in the healthcare practice, particularly among younger nurses. Finally, the major reservations perceived were related to privacy and patient confidentiality, and lack of time to learn how to use, or use ICTs.
Collapse
|
40
|
Cherrez-Ojeda I, Vanegas E, Felix M, Cherrez S, Suárez-Almendariz D, Ponton J, Preciado V, Ollague-Cordova E, Loayza E. Alexithymia in Patients with Psoriasis: A Cross-Sectional Study from Ecuador. Psychol Res Behav Manag 2020; 12:1121-1126. [PMID: 31908550 PMCID: PMC6924577 DOI: 10.2147/prbm.s227021] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2019] [Accepted: 12/03/2019] [Indexed: 01/23/2023] Open
Abstract
Objective We designed this study to determine the frequency of alexithymia in Ecuadorian patients with psoriasis, as well as possible associations between demographic factors, disease severity, and treatment adherence. Methods A cross-sectional study involving 99 Ecuadorian patients with psoriasis was conducted. Multinomial logistic regressions were performed to ascertain whether age, gender, educational level, years with disease, psoriasis area and severity index (PASI) scores, and treatment adherence categories are prediction factors in patients with psoriasis to present alexithymia, possible alexithymia or no alexithymia. Results A total of 99 patients participated in the study with a gender distribution of 57.6% male, and an average age and years with disease of 48.3 and 7.4, respectively. Out of all patients, 33.3% presented alexithymia, and 22.2% possible alexithymia, as assessed by the Toronto Alexithymia Scale (TAS-20). The multiple regression model statistically significantly predicted the TAS-20 score from age, gender, educational level, years with psoriasis, PASI score and level of adherence F (7,88) = 4.171, p = 0.001, adj. R2= 0.189. Only having the highest educational level added statistical significance to the prediction of having a lower TAS-20 score, whilst the remainder variables did not. Conclusion We found a similar proportion of alexithymia, as well of average TAS-20 scores among Ecuadorian patients with psoriasis in comparison to previous studies. Only having the highest educational level was found to decrease the TAS-20 score. Age, gender, years with psoriasis, PASI score and level of adherence were not identified as factors that influence the TAS-20 score.
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Sofia Cherrez
- Respiralab Research Group, Guayaquil, Ecuador.,School of Medicine, University of Heidelberg, Heidelberg, Germany
| | | | - Johana Ponton
- Departamento de Dermatología, Hospital Luis Vernaza, Guayaquil, Ecuador
| | | | | | - Enrique Loayza
- Departamento de Dermatología, Hospital Luis Vernaza, Guayaquil, Ecuador
| |
Collapse
|
41
|
Ortiz I, Felix M, Resende H, Love C, Hinrichs K. 120 Use of fixable dyes to analyze equine sperm membrane integrity and acrosome reaction after A23187 treatment. Reprod Fertil Dev 2020. [DOI: 10.1071/rdv32n2ab120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Conventional IVF is not successful in the horse, and current work is focused on factors affecting sperm capacitation in this species. Challenges arise in assessing equine sperm incubated in media containing capacitation promotors, as some of these factors cause sperm head-to-head binding (aggregation). Our preliminary microscopic findings showed that sperm aggregates are largely of viable sperm, whereas nonviable sperm individualize. Thus, data obtained using technologies that analyse only individual cells and gate out aggregates, such as flow cytometry, may not accurately represent the study population. We developed a fixable live/dead/acrosome staining protocol (LD-PSA) that minimizes sperm aggregation. The aim of this study was to evaluate the percentage of viable and acrosome-reacted equine sperm after A23187 treatment, using either LD-PSA or a standard staining protocol (PI-PSA). Sperm from 9 ejaculates were suspended in Hanks’ balanced salt solution (HBSS) and exposed for 10min at 37°C to vehicle (V) or to 10 µM A23187 (C10). The sperm were washed, resuspended in HBSS medium with added lactate and pyruvate and containing 7mgmL−1 of bovine serum albumin (BSA), and assessed immediately (0h) or incubated at 37°C for 2h (the period needed for equine sperm to respond to A23187). Motility was analysed using computer-assisted semen analysis. Each treatment was stained by PI-PSA: propidium iodide and fluorescein isothiocyanate-Pisum sativum agglutinin (PSA) in DPBS; and by LD-PSA: Live/Dead Fixable Red, paraformaldehyde 2%, Triton×1%, and FITC-PSA in Dulbecco's phosphate-buffered saline with Accumax (Stem Cell Technologies), a commercial proprietary cell agglutination inhibitor, before flow cytometric analysis. Differences were analysed using repeated-measures two-way ANOVA. The% total motile sperm (TMOT) for V and C10 treatments were 76.3±3.0 and 71.2±4.7 at 0h (P>0.05), and 70.5±14.8 and 2.4±0.8 at 2h (P<0.05). On flow cytometry, the percentage of events outside the gate for V sperm (0h and 2h combined) was 31.9% in PI-PSA and 21.9% in LD-PSA samples (P<0.01). Measured viability in V samples was significantly lower when stained with PI-PSA than with LD-PSA at 0h (49.2±4.6 vs. 67.1±4.9) and tended to be lower (P=0.07) at 2h (44.0±4.9 vs. 55.1±2.8). Notably, the viability recorded in PI-PSA was 26 percentage points lower than was the TMOT at both 0h and 2h, indicating nonrepresentative results, as nonviable sperm should not be motile. By LD-PSA, this difference was 9 points at 0h and 15 points at 2h. Vehicle sperm showed significantly higher AR values in PI-PSA than in LD-PSA at 0h (30.4±4.0 vs. 17.7±2.4) and 2h (41.9±4.5 vs. 24.0±1.8), as did C10 sperm at 0h (28.9±2.7 vs. 18.0±2.5). The lower values for viability than total motility likely reflect agglutination of viable sperm and thus their exclusion from analysis on flow cytometry. The anti-clumping measures employed in the LD-PSA protocol were associated with increased correspondence of measured viability with TMOT. Thus, LD-PSA may offer a more accurate technique to assess viability and acrosome status of equine sperm incubated in capacitating conditions.
Collapse
|
42
|
Felix M, Ortiz I, Resende H, Brom-de-Luna J, Love C, Hinrichs K. 121 Effect of pentoxifylline on motility of good- and poor-quality frozen-thawed equine sperm. Reprod Fertil Dev 2020. [DOI: 10.1071/rdv32n2ab121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Equine semen used for intracytoplasmic sperm injection (ICSI) is typically frozen-thawed and may be of poor quality. To prepare sperm for ICSI, semen is typically centrifuged to remove freezing extender. However, centrifugation can cause damage to sperm, which is especially meaningful if sperm quality is already poor. We evaluated a method for selection of sperm without centrifugation, using a “swim-over” technique, and assessed the effect of pentoxifylline, a phosphodiesterase inhibitor that increases sperm motility in other species. To mimic poor-quality semen, we thawed frozen semen (1×) and re-froze it three additional times (4×). Aliquots (0.25 µL; 50,000 sperm) of 1× or 4× semen were placed at the bottom of the right leg of an “H,” made using 15µL of medium by tracing a template placed below a Petri dish. The medium used (Hanks’ balanced salt solution with 40mg mL BSA and added lactate and pyruvate) contained different concentrations of pentoxifylline (0, 0.5, 1, 2 or 4mgmL−1). One µL of medium was removed from the tip of the left arm of the H after 15 and 30min incubation, and the number of sperm were counted. In a second study, we evaluated the effect of pentoxifylline on sperm motility parameters using computer-assisted sperm motility analysis. After thawing, 1× and 4× semen was washed to remove freezing extender and resuspended in the same medium but with 7mgmL−1 bovine serum albumin (BSA), containing the different pentoxifylline concentrations. In Study 1, the number of collected sperm did not differ significantly for 1× sperm exposed to 0 to 4mgmL−1 pentoxifylline (means of 15 to 23 sperm at 15min, and 18 to 25 sperm at 30min). Similarly, in 4× frozen semen, there was no significant difference in number of collected sperm between 0mgmL−1 and 2 or 4mgmL−1 pentoxifylline concentrations (<1 to 6 at 15 min; 5 to 6 at 30min). In Study 2, at 0min,% total motility was significantly higher in 1 and 2mgmL−1 pentoxifylline than in 0mgmL−1 for 1× sperm (47.8±1.7 and 49.3±1.9, vs. 32.1±3.9, respectively; P=0.018) and significantly higher for 1, 2, and 4mgmL−1 pentoxifylline than for 0mgmL−1 for 4× sperm (3.9±0.9, 5.7±0.4, and 8.2±0.5, vs. 1.2±0.4; P=0.0001). Similar results were found at 15 and 30min for 1×, and at 15min for 4×. Pentoxifylline at 1 to 4mgmL−1 significantly increased the percentage of progressive motility in 1× sperm at 30min (17.8±1.3, 21.8±2.7, and 20.3±1.2, vs. 10.0±0.4; P=0.002) and, at 4mgmL−1, increased the percentage of progressive motility in 4× sperm at 0min (1.43±0.1 vs. 0.2±0.1; P=0.005) and 15min (1.4±0.2 vs. 0.1±0.0; P=0.0001). Exposure of poor-quality semen to pentoxifylline at 4mgmL−1 improved total and progressive motility but did not increase the recovery of motile sperm in a swim-over collection preparation.
Collapse
|
43
|
Cherrez-Ojeda I, Haddad M, Vera Paz C, Valdevila Figueira JA, Fabelo Roche J, Orellana Román C, Iglesias Moré S, Felix M, Vanegas E, Alvarado-Villa GE. Spanish Validation Of The Revised Depression Attitude Questionnaire (R-DAQ). Psychol Res Behav Manag 2019; 12:1051-1058. [PMID: 32009821 PMCID: PMC6859125 DOI: 10.2147/prbm.s228249] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Accepted: 10/25/2019] [Indexed: 12/15/2022] Open
Abstract
Purpose The aim of the study was to develop and validate a Spanish version of the Revised Depression Attitude Questionnaire (R-DAQ). Methods The R-DAQ was used as a baseline for the study. It was translated and tested to ensure the instrument was appropriate for the target population. 537 Ecuadorian healthcare professionals completed the revised Spanish version of the R-DAQ (SR-DAQ). Statistical and exploratory factor analyses were performed to examine construct validity, internal consistency, readability and floor and ceiling effects. Results Three factors were obtained: “Professional confidence in depression care”; “Therapeutic optimism about depression”; and “Generalist perspective about depression occurrence, recognition, and management”. The internal consistency of the SR-DAQ was determined by means of Cronbach’s α coefficient, with values ranging between 0.61–0.8. The correlations with the English version reflected adequate validity. The model explained 39% of the variance. Subsequent analysis with a sample restricted to those who had received training in depression produced a model that explained 42% of the variance. Conclusion The SR-DAQ meets the psychometric requirements for measuring depression attitude in a Spanish-speaking population and shows adequate internal consistency and validity.
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Mark Haddad
- Centre for Mental Health Research, School of Health Sciences, City University London, London, UK
| | - Carlos Vera Paz
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | | | | | | | | | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | | |
Collapse
|
44
|
Makdisse M, Ramos P, Malheiro D, Cypriano A, Soares J, Carneiro A, Felix M, Neto M, Klajner S. PNS42 A SURVEY OF PRACTICING PHYSICIANS ON VALUE-BASED HEALTH CARE IN A PRIVATE HEALTH SYSTEM IN BRAZIL. Value Health Reg Issues 2019. [DOI: 10.1016/j.vhri.2019.08.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Ramon GD, Barrionuevo LB, Viego V, Vanegas E, Felix M, Cherrez-Ojeda I. Sensitization to subtropical grass pollens in patients with seasonal allergic rhinitis from Bahia Blanca, Argentina. World Allergy Organ J 2019; 12:100062. [PMID: 31641410 PMCID: PMC6796778 DOI: 10.1016/j.waojou.2019.100062] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Revised: 07/16/2019] [Accepted: 07/24/2019] [Indexed: 11/30/2022] Open
Abstract
Background Grass pollinosis is an important contributor to allergic diseases, with varying patterns and frequency of allergens according to the geographical location studied. Our study aims to provide a better understanding of subtropical grass pollinosis in Argentinian patients with seasonal allergic rhinitis. Methods We conducted a retrospective cross-sectional study involving 894 patients with seasonal allergic rhinitis from Bahía Blanca, Argentina. Skin prick tests were performed to selected pollen species belonging to three subfamilies of the Poaceae genera. Frequency of sensitization to specific grass pollen extracts, cross-reactivity of allergens assessed by skin prick test, and possible associations between allergen extracts and asthma or allergic conjunctivitis were analyzed. Results Sensitization to the Pooideae subfamily was the most frequent, encompassing 86.8% (CI: 84.4%–88.9%) of the studied population. Positive reactions to allergen extracts from the Chloridoideae and the Panicoideae subfamilies showed smaller papule size than allergen extracts from the Pooideae subfamily (χ2(5) = 83.75, p < 0.001). Patients with a positive skin prick test (SPT) to a specific extract were more likely to present some degree of cross-reactivity to the remaining pollens when compared to patients with negative SPT to the same specific extract. Even though the proportion of patients presenting with asthma (46.9%) was higher than those with conjunctivitis (22.6%), there was only a statistically significant association between sensitization to Festuca arundinacea (φ = 0.089, p = .009), Phalaris arundinacea (φ = 0.074, p = .032) and Paspalum notatum (φ = 0.070, p = .038) and the presence of conjunctivitis. Conclusions Our results suggest a high frequency of sensitization to grass pollen extracts from the Poaceae family among patients with seasonal allergic rhinitis. Overall, sensitization to the Pooidae subfamily was the most common, where Phalaris arundinacea presented the highest frequency.
Collapse
Affiliation(s)
- German D Ramon
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Argentina
| | | | - Valentina Viego
- Universidad Nacional del Sur, SCyT UNS 24/E134, Bahía Blanca, Argentina
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group. Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group. Guayaquil, Ecuador
| | - Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador.,Respiralab, Respiralab Research Group. Guayaquil, Ecuador
| |
Collapse
|
46
|
Chérrez-Ojeda I, Vanegas E, Felix M, Mata VL, Gavilanes AW, Chedraui P. Use and preferences of information and communication technologies in patients with hypertension: a cross-sectional study in Ecuador. J Multidiscip Healthc 2019; 12:583-590. [PMID: 31413585 PMCID: PMC6661996 DOI: 10.2147/jmdh.s208861] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Accepted: 07/04/2019] [Indexed: 12/17/2022] Open
Abstract
Objectives This study was designed to assess the use and preferences for information and communication technologies (ICTs) among patients with hypertension in Ecuador. Methods We conducted an anonymous cross-sectional study during 2018, in which 207 patients with hypertension were surveyed using an adapted version of the Michigan questionnaire. The survey included 16 questions in total, in which patients were asked to quantify their use for each ICT, and their interest in using ICTs to receive information and communicate with health care providers. Adjusted binomial and multinomial regression analyses were performed. Results Of the surveyed population, 74.9% of patients reported owning a smartphone, while 79.2% of responders reported having access to the internet. In general, web-based internet (53.7%) remains the main source for obtaining information related to hypertension, followed by YouTube (39.5%) and Facebook (30.2%). WhatsApp and Facebook were rated with the highest interest for receiving and asking health-related information. Older age and lower educational levels were consistently associated with less interest and usage for most ICTs. Conclusions The widespread use of ICTs opens new possibilities for improving the care of patients with hypertension through self-management education strategies. Further studies should be conducted to demonstrate how to develop and promote interventions through ICTs more effectively, based on the studied patterns of use and preferences of ICTs for specific patients.
Collapse
Affiliation(s)
- Ivan Chérrez-Ojeda
- Universidad Espíritu Santo , Samborondón, Ecuador.,Respiralab Research Group , Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo , Samborondón, Ecuador.,Respiralab Research Group , Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo , Samborondón, Ecuador.,Respiralab Research Group , Guayaquil, Ecuador
| | - Valeria L Mata
- Universidad Espíritu Santo , Samborondón, Ecuador.,Respiralab Research Group , Guayaquil, Ecuador
| | - Antonio Wd Gavilanes
- Department of Pediatrics, Maastricht University Medical Center, Maastricht, the Netherlands.,School of Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands
| | - Peter Chedraui
- Instituto De Investigación E Innovación En Salud Integral, Facultad De Ciencias Médicas, Universidad Católica De Santiago De Guayaquil, Guayaquil, Ecuador.,Facultad De Ciencias De La Salud, Universidad Católica "Nuestra Señora De La Asunción", Asunción, Paraguay
| |
Collapse
|
47
|
Cherrez-Ojeda I, Vanegas E, Mata VL, Felix M, Ramon GD, Cherrez S, Cherrez A. Autoimmune thyroid disease and urticarial vasculitis: is there a significant association? Allergy Asthma Clin Immunol 2019; 15:25. [PMID: 31019538 PMCID: PMC6471945 DOI: 10.1186/s13223-019-0339-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2018] [Accepted: 04/04/2019] [Indexed: 11/10/2022] Open
Abstract
Little is known about the association of urticarial vasculitis (UV) with thyroid autoimmunity. The latter has been mostly described in the setting of patients with chronic spontaneous urticaria (CSU). In this letter to the editor, we compare UV and CSU through retrospective analyses, which reveal that 41.7% patients with UV presented antithyroperoxidase (anti-TPO) and/or antithyroglobulin antibody (ATA) above the reference range, while only 4% patients with CSU had these antibodies elevated. There is a moderately strong association assessed by the Phi coefficient (φ = 0.420, p = 0.004). Further research is needed to appropriately address the relationship between UV and thyroid autoimmunity and explore any potential underlying pathophysiological process between both diseases.
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- 1Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Samborondón, Zip code: 0901-952 Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- 1Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Samborondón, Zip code: 0901-952 Ecuador.,Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Valeria L Mata
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - German D Ramon
- Allergy Section, Hospital Italiano Regional del Sur, Bahía Blanca, Argentina
| | - Sofia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,4University of Heidelberg, Heidelberg, Germany
| | - Annia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador.,Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, Rostock, Germany
| |
Collapse
|
48
|
Perez‐Puyana V, Felix M, Romero A, Guerrero A. Influence of the processing variables on the microstructure and properties of gelatin‐based scaffolds by freeze‐drying. J Appl Polym Sci 2019. [DOI: 10.1002/app.47671] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- V. Perez‐Puyana
- Departamento de Ingeniería Química, Facultad de QuímicaUniversidad de Sevilla 41012 Sevilla Spain
| | - M. Felix
- Departamento de Ingeniería Química, Escuela Politécnica SuperiorUniversidad de Sevilla 41011 Sevilla Spain
| | - A. Romero
- Departamento de Ingeniería Química, Facultad de FísicaUniversidad de Sevilla 41012 Sevilla Spain
| | - A. Guerrero
- Departamento de Ingeniería Química, Escuela Politécnica SuperiorUniversidad de Sevilla 41011 Sevilla Spain
| |
Collapse
|
49
|
Cherrez-Ojeda I, Maurer M, Bernstein JA, Vanegas E, Felix M, Ramon GD, Ensina LF, Larco Sousa JI, Matos Benavides EE, Cardona Villa R, Latour Staffeld P, Morfin-Maciel BM, Mori J, Wilches C P, Mata VL, Cherrez A. Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America. World Allergy Organ J 2019; 12:100011. [PMID: 30937137 PMCID: PMC6439401 DOI: 10.1016/j.waojou.2019.100011] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Revised: 12/20/2018] [Accepted: 01/08/2019] [Indexed: 11/19/2022] Open
Abstract
Background Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation antihistamines as the cornerstone in therapy for chronic urticaria (CU), while other drugs, such as omalizumab, are conceived as second-line alternatives. In regards to omalizumab, despite advances in the management of CU, there are still open questions about timing, dosing, and objective measures for clinical response. This study was designed to portray the use of patient-reported outcomes (PROs) in chronic urticaria management, as well as the effectiveness and treatment patterns of omalizumab in CU, as seen in a real-life setting in Latin America. Methods This is a retrospective observational study, involving 72 Latin American patients with chronic urticaria treated with omalizumab. Patient reported outcomes and treatment patterns, response, quality of life improvement and discontinuation were analyzed. Results From the 72 patients, 91.7% (n = 66) were assessed through PROs, where urticaria control test (UCT) was the most used (79.2%; n = 57). Overall, 80.0% (n = 44) responded to omalizumab at some point of the treatment. Omalizumab 300 mg was associated with earlier response compared to lower doses. Regardless of dosage, most patients assessed with CU-Q2oL improved quality of life (80.8%; n = 21). With respect to omalizumab discontinuation, 20.8% (n = 15) patients interrupted omalizumab before the 3rd month of treatment (p = .000). Conclusions The present study highlights how the use of PROs and omalizumab in Latin America differ from guidelines' recommendations and clinical trials. Even though most patients were initiated under omalizumab 300 mg, most of them finished with lower doses. Regardless of dosage, most patients responded to omalizumab and improved quality of life at some point during treatment. However, such features were seen earlier with omalizumab 300 mg. Regarding treatment discontinuation, one-fifth of patients interrupted omalizumab before the third month.
Collapse
Key Words
- CU, chronic urticaria
- CU-Q2oL, chronic urticaria quality of life questionnaire
- Chronic spontaneous urticaria
- EAACI/GA2LEN/EDF/WAO, European Academy of Allergology and Clinical Immunology
- Global Allergy and Asthma European Network, European Dermatology Forum and World Allergy Organization
- LA, Latin America
- Latin America
- MCID, minimal clinical important difference
- Omalizumab
- PRO, patient-reported outcomes
- Patient-reported outcomes
- Quality of life
- SD, standard deviation
- UAS7, urticaria activity score 7
- UCT, urticaria control test
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
- Corresponding author. Iván Chérrez Ojeda, Universidad Espíritu Santo, Km. 2.5 vía La Puntilla, Samborondón, Ecuador. Código postal: 0901-952.
| | - Marcus Maurer
- Department of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Jonathan A. Bernstein
- University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Immunology/Allergy Section, Cincinnati, OH, United States
| | - Emanuel Vanegas
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - German D. Ramon
- Instituto de Alergia e Inmunología del Sur, Bahía Blanca, Prov. de Buenos Aires, Argentina
| | | | | | | | | | - P. Latour Staffeld
- Centro Avanzado de Alergia y Asma de Santo Domingo, Santo Domingo, Dominican Republic
- Universidad Nacional Pedro Henriquez Ureña, Santo Domingo, Dominican Republic
| | | | | | - Paul Wilches C
- Unidad de Asma y Alergia del Hospital Monte Sinai, Cuenca, Ecuador
| | - Valeria L. Mata
- Universidad Espíritu Santo, Samborondón, Ecuador
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
| | - Annia Cherrez
- Respiralab, Respiralab Research Group, Guayaquil, Ecuador
- University Hospital, Dermatology Department, Rostock, Germany
| |
Collapse
|
50
|
Cherrez-Ojeda I, Felix M, Vanegas E, Mata VL, Jimenez FM, Ugarte Fornell LG. Rhonchus and Valve-Like Sensation as Initial Manifestations of Long-Standing Foreign Body Aspiration: A Case Report. Am J Case Rep 2019; 20:70-73. [PMID: 30651531 PMCID: PMC6345106 DOI: 10.12659/ajcr.913405] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
Abstract
Patient: Male, 52 Final Diagnosis: Foreign body aspiration Symptoms: Rhonchus • thoracic valve-like sensation Medication: — Clinical Procedure: — Specialty: Pulmonology
Collapse
Affiliation(s)
- Ivan Cherrez-Ojeda
- Universidad Espíritu Santo (Holy Spirit University), Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Miguel Felix
- Universidad Espíritu Santo (Holy Spirit University), Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Emanuel Vanegas
- Universidad Espíritu Santo (Holy Spirit University), Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Valeria L Mata
- Universidad Espíritu Santo (Holy Spirit University), Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | - Fanny M Jimenez
- Universidad Espíritu Santo (Holy Spirit University), Samborondón, Ecuador.,Respiralab Research Group, Guayaquil, Ecuador
| | | |
Collapse
|